GA MPJE Review qustions

A hospital pharmacy shall have within the hospital which it serves, sufficient floor space allocated to it to insure that drugs are prepared in sanitary, well-lighted and enclosed places, and which meet the other requirements of this section and the Georgia Pharmacy Laws. The hospital pharmacy space requirements should be a minimum of _____________ per hospital bed, which includes all areas assigned and under the direct control of the Director of Pharmacy. A. 10 square feet B. 20 square feet C. 50 square feet D. 100 square feet

Answer: (a) 10 square feet [GA Rule 480-13-.05(1). Physical Requirements.]. A hospital pharmacy shall have within the hospital which it serves, sufficient floor space allocated to it to insure that drugs are prepared in sanitary, well-lighted and enclosed places, and which meet the other requirements of this section and the Georgia Pharmacy Laws. The hospital pharmacy space requirements should be a minimum of 10 square feet per hospital bed, which includes all areas assigned and under the direct control of the Director of Pharmacy. The pharmacy of substance abuse treatment or mental health facility shall be exempt from the minimum square footage requirement provided that the pharmacy receives a satisfactory inspection from the Georgia Drugs and Narcotics Agency that shows that the pharmacy space is sufficient to supply the needs of the patients and that all aspect of the management and operations of the pharmacy comply with the law and the rules of the Board to ensure that the health, safety, and welfare of the patients served by the pharmacy are protected. No application for licensure of a pharmacy of a substance abuse treatment or mental health facility seeking an exemption shall be approved without a satisfactory inspection.

Each dispenser shall submit a controlled substance prescription information to the Department of Public Health (PDMP) at least every _________. A. 24 hours B. 48 hours C. 72 hours D. 7 days

Answer: (a) 24 hours, [Rules of Georgia State Board of Pharmacy Title 16, 16-13-59(b)]. The department shall, in consultation with members of the Georgia Composite Medical Board, the State Board of Pharmacy, and the agency, establish and maintain a program to electronically record into an electronic PDMP prescription information resulting from the dispensing of Schedule II, III, IV, or V controlled substances and to electronically review such prescription information that has been entered into such data base.   The purpose of such PDMP shall be to assist in the reduction of the abuse of controlled substances;  to improve, enhance, and encourage a better quality of health care by promoting the proper use of medications to treat pain and terminal illness;  to reduce duplicative prescribing and overprescribing of controlled substance practices, for health oversight purposes;  and to gather data for epidemiological research.   The PDMP shall be administered by the department. Each dispenser shall submit a controlled substance prescription information to the Department of Public Health (PDMP) at least every 24 hours.

Nonresident pharmacy permit holders must update the Board within what time frame for any change in pharmacist-in-charge of Non Resident Pharmacy? A. 72 hours B. 7 days C. 30 days D. Immediately

Answer: (a) 72 hours, [Rules of Georgia State Board of Pharmacy 480-6-.02(16)]. It shall be unlawful for any person, pharmacy, or facility located outside this state to ship, mail, or deliver prescription drugs orders into this state or to advertise its services, personally or through an in-state third party, unless such person, pharmacy or facility holds a pharmacy license pursuant to O.C.G.A. Section 26-4-110.1, or holds a nonresident pharmacy permit pursuant to O.C.G.A. Section 26-4-114.1, or is otherwise exempt from Georgia registration as a matter of Georgia law. Registration of a nonresident pharmacy permit will be considered on the basis of the application filed with the Board, fee paid, and a report from the Director of the GDNA certifying the applicant possesses the necessary qualifications for a permit. Permits are issued for two years and expire on June 30th of each odd-numbered year, and may be renewed for two years upon the payment of the required fee for each place of business and the filing of a completed application for renewal. If the application for renewal is not made and the fee not paid before September 1st of the odd-numbered year, the permit shall lapse and shall not be renewed, and an application for reinstatement shall be required. Reinstatement is at the sole discretion of the Board. Nonresident pharmacy permit holders shall comply with all the recordkeeping requirements of the state in which they are located and licensed for all prescriptions shipped, mailed or delivered to patients or practitioners in the State of Georgia, but shall be maintained a minimum of two (2) years. Nonresident pharmacy permit holders shall notify the Board of each location where the required records are being maintained, and such records must be readily retrievable and produced to the Board within fifteen (15) business days, upon written request. Within 72 hours**, nonresident permit holders must update the Board of any change in pharmacist-in-charge of shipping into Georgia by completing forms provided by the Board and including such pharmacist licensure information and criminal history. Where a criminal background check cannot be completed within the seventy-two (72 hours) contemplated by this section, nonresident pharmacy permit holders must still update the Board of any change in pharmacist-in-charge of shipping into Georgia by completing forms provided by the Board and including such pharmacist licensure information, but shall have up to fifteen (15) business days to provide criminal history information. **Please note for In-State Georgia Pharmacies, the pharmacy permit holder shall immediately notify any change in pharmacist-in-charge of said pharmacy.**

According to Georgia State Pharmacy Law, the prescription record should be kept on file for: A. Two years from the date of dispensing. B. Five years from the date of dispensing. C. Three years from the date of dispensing. D. A year from the date of dispensing.

Answer: (a) According to Georgia State Pharmacy Law, the prescription record should be kept on file for two years from the date of dispensing, [Rules of Georgia State Board of Pharmacy 480-27-.03]. Records of dispensing for original and refill prescriptions are to be made and kept by pharmacies for two years and shall include, but not be limited to: (a). Quantities dispensed; (b). Date of dispensing; (c). Serial number (or equivalent if an institution); (d). The identification of the pharmacist responsible for dispensing; (e). Documentation of satisfaction of state requirements for drug product selection; (f). Records of refills to date to include date(s) of refills, and identification of pharmacist(s) dispensing refills.

After dispensing an emergency Schedule II drug, the pharmacist shall notify which of the following upon not receiving a written prescription from the prescriber within 7 days? I. The Georgia Drugs and Narcotics Agency II. The Georgia State Board of Pharmacy III. The DEA A. I only B. I and II only C. II and III only D. All

Answer: (a) After dispensing an emergency Schedule II drug, the pharmacist shall notify the Georgia Drugs and Narcotics Agency upon not receiving a written prescription from the prescriber within 7 days of an emergency oral authorization, [Rules of Georgia State Board of Pharmacy 480-22-.04(3)(d)].

Which of the following is/are TRUE about dispensing non-pseudoephedrine Schedule V controlled substances according to the Georgia Controlled Substances Act? I. A physician or medical practitioner may dispense Schedule V substances for legitimate medical purposes in the normal course of his professional practice. II. A registered pharmacist may sell, dispense or otherwise dispose of without prescription not more than 4 oz. or 32 dosage units of a Schedule V substance within any 96 hour period of time. III. No person shall obtain or attempt to obtain, in any 48-hour period of time, more than 8 oz. or 64 dosage units of a Schedule V substance. A. I only B. I and II only C. II and III only D. All

Answer: (a) I is true. Requirements for Schedule V controlled substances, [Rules of Georgia State Board of Pharmacy 480-19-.01(a)-to-(c),.02]: (a). A physician or medical practitioner may dispense Schedule V substances for legitimate medical purposes in the normal course of his professional practice. (b). A licensed pharmacist, or intern acting under the immediate and direct supervision of a licensed pharmacist, may sell, dispense or otherwise dispose of without prescription not more than 4 oz. or 32 dosage units of an exempted non-pseudoephedrine Schedule V controlled substance within any 48 hour period of time, but only: 1. After applying reasonable means or effort to determine that such is to be used for legitimate medical purposes; and 2. After the purchaser has written his/her signature, date of birth, address, city, state and zip code upon a register which records and reflects the date of such transaction, the name, kind, quantity and intended use of such Schedule V substance sold, dispensed, or otherwise disposed of, and such records shall be maintained as required by Schedule V records. (c). No person shall obtain or attempt to obtain, in any 48-hour period of time, more than 4 oz. or 32 dosage units of a Schedule V controlled substance. (2). Before the sale of any non-pseudoephedrine Schedule V Controlled Substance without a prescription, a licensed pharmacist should first determine whether or not the product to be sold is packaged in a container with not more than 4 ounces or 32 dosage units of the drug, and whether the label provided by the product manufacturer contains a Federal Caution or Warning. If such Legend or Warning or Rx Only indication is present on the manufacturer’s label, this product cannot be sold without a prescription.

During a state of emergency, the pharmacist may dispense up to a 30 day supply in the counties or areas affected by such emergency provided that: I. In the pharmacist's professional judgment, the interruption of such therapy might reasonably produce undesirable health consequences or cause physical or mental discomfort. II. The prescription is not for a controlled substance. III. The dispensing pharmacist notifies the prescriber of the emergency dispensing within 7 days after such dispensing. A. I only B. I and II only C. II and III only

Answer: (a) I only, [GA Law 26-4-80 (f)(1)]. If the Governor has issued an executive order or proclamation declaring a state of emergency or the National Weather Service has issued a hurricane warning, the pharmacist may dispense up to a 30 day supply in the counties or areas affected by such order, proclamation, or warning, provided that: (A). The prescription is not for a Schedule II controlled substance (schedule III, IV and V are allowed); (B). In the pharmacist's professional judgment, the prescription is essential to the maintenance of life or to the continuation of therapy for a chronic condition; (C). In the pharmacist's professional judgment, the interruption of such therapy might reasonably produce undesirable health consequences or cause physical or mental discomfort; (D). The dispensing pharmacist creates and signs a written order containing all of the prescription information required by this article and by Chapter 13 of Title 16; and (E). The dispensing pharmacist notifies the prescriber of the emergency dispensing within 48 hours (not within 7 days) after such dispensing and each such dispensing thereafter.

Which of the following is/are TRUE regarding drugs included in HOSPICE emergency kits? I. A record of the drugs to be kept in an emergency drug kit must be kept in the hospice and the provider pharmacy. II. A valid, signed prescription drug order for any such drug must be issued to the vendor pharmacy supplying the emergency drug kit within 48 hours of the drug being taken from the kit. III. An emergency drug kit must be inventoried once a week by a pharmacist from the provider pharmacy and they must sign a card attached to the kit indicating the date it was inspected. A. I only B. I and II only C. II and III only D. All

Answer: (a) I only, [Rules of Georgia State Board of Pharmacy 480-24-.07(1)-to-(7)]. Emergency Drug Kits may be placed in licensed hospices by the pharmacy of the consultant or vendor pharmacist provided the following guidelines are met: (1). A record of the drugs to be kept in an emergency drug kit must be kept in the hospice and the provider pharmacy. (2). Drugs shall not be accessed for use from the emergency drug kit in an emergency situation without a new prescription drug order from a licensed practitioner. A valid, signed prescription drug order for any such drug must be issued to the vendor pharmacy supplying the emergency drug kit within 72 hours (NOT 48 hours) of the drug being taken from the kit. (3). Emergency drug kits shall be stored in limited access areas and sealed to prevent unauthorized access and to insure a proper environment for preservation of the drugs therein. The provider pharmacy shall develop a method to readily determine if an emergency drug kit has been accessed without authorization. (4). An emergency drug kit must be inventoried once a MONTH (NOT week) by a pharmacist from the provider pharmacy and they must sign a card attached to the kit indicating the date it was inspected. The provider pharmacy must maintain an adequate record of such inspections. (5). Special Agents of the GDNA shall have the authority to check emergency drug kits as well as the records in the provider pharmacy to determine that drugs and records are accurate and the emergency drug kit is being properly used. (6). The provider pharmacy must apply on an individual basis to the Board, in care of the GDNA Director, for approval to place an emergency drug kit in each individual hospice and a copy of this approval will be kept on file in both the hospice and the provider pharmacy. Upon recommendation by the GDNA Director, the Board may revoke the approval for an emergency drug kit in any hospice where abuse or misuse of drugs from the emergency drug kit is used for any purpose other than emergency purposes. (7). The Board shall have the authority to approve on an individual basis the drugs and the amounts of each individual drug allowed to be kept in an emergency drug kit. Any change in the drugs and amounts kept in a kit must be submitted in writing to the GDNA Director who shall make recommendations to the Board. After Board approval, a copy of this approval will be maintained in the GDNA provider pharmacy file and by the nursing home. Any emergency drug kit approval becomes null and void once the approved pharmacy ceases to provide that kit.

Pharmacies may transfer the prescription for controlled III, IV and V substances: A. one time B. two times C. three times D. four times

Answer: (a) One time. Pharmacies may transfer the prescription for controlled III, IV and V substances only one time, [Rules of Georgia State Board of Pharmacy 480-22-.11(1),(2)]. However, pharmacies electronically sharing a real-time, online computerized database may transfer the prescription drug order information as many times as there are authorized refills, up to the maximum of five (5) times, if it is within six (6) months from the date of issuance. (2). A transfer is considered a communication between two licensed pharmacists and/or pharmacy interns/externs. Transfers are subject to the following requirements: (a). The transferring pharmacist or pharmacy intern/extern shall record the following information in either real time or at the first opportunity after the transfer: 1. The word "VOID" must be written on the face of the original, hard copy, invalidated prescription drug order; 2. The following must be written on the back of the original, invalidated prescription drug order: the name, address, telephone number, and DEA number of the pharmacy to which it is transferred, and the name of the pharmacist receiving the prescription information; and 3. The date of the transfer and the name of the pharmacist transferring the information must be recorded on the back of the prescription drug order. (b). The pharmacist or pharmacy intern/extern receiving the transferred prescription drug order information shall reduce it to writing and record the following information: 1. The word "TRANSFER" shall be written on the face of the transferred prescription drug order hard-copy; 2. All information required to be recorded on a prescription drug order pursuant to this chapter, which shall include: (i). Date the prescription drug order was originally issued by the prescribing practitioner; (ii). The number of refills authorized on the original prescription drug order. (c). Date the prescription drug order was originally dispensed by the transferring pharmacy; (d). Number of valid refills remaining, and date(s) and pharmacy location(s) where any previous refills were dispensed; (e). The pharmacy’s name, address, telephone number, DEA number, and prescription serial number from which the prescription information was transferred; and (f). The name of the pharmacist who transferred the prescription drug order. (3). The original and transferred prescription(s) must be maintained for a period of 30 months from the date of the last refill. (4). Pharmacies electronically transferring a prescription drug order for the purpose of refills must maintain the same information and record keeping requirements as do pharmacies with manual, non-electronic record keeping systems.

If the National Weather Service has issued a hurricane warning, the pharmacist may dispense up to a 30 day supply in the counties or areas affected by such warning. A. True B. False

Answer: (a) True, [GA Law 26-4-80 (f)(1)]. When filling a prescription or refilling a prescription which may be refilled, the pharmacist shall exercise professional judgment in the matter. No prescription shall be filled or refilled with greater frequency than the approximate interval of time that the dosage regimen ordered by the practitioner would indicate, unless extenuating circumstances are documented which would justify a shorter interval of time before the filling or refilling of the prescription. Such circumstances may include but are not limited to instances in which, with regard to a particular county or area of this state, the Governor has issued an executive order or proclamation declaring a state of emergency or the National Weather Service has issued a hurricane warning, the pharmacist may dispense up to a 30 day supply in the counties or areas affected by such order, proclamation, or warning.

In case of prescription processing through central filling services, it shall be the responsibility of the pharmacist on duty at the originating pharmacy to perform patient counseling of all prescriptions. A. True B. False

Answer: (a) True, [GA Rule 480-10A-.07. and GA Rule 480-10A-.08]. (1). It shall be the responsibility of the pharmacist on duty at the originating pharmacy to perform patient counseling of all prescriptions. (2). The central fill pharmacy shall not perform patient counseling on behalf of the originating pharmacy. (3). An originating pharmacy that utilizes central filling services must, prior to outsourcing the prescription, notify patients that prescription filing may be outsourced to another pharmacy. (a). The patient shall have the choice to not have the prescription outsourced. (b). Notification may be provided through the use of a sign located in the originating pharmacy which is clearly visible to and readable by the public.

A temporary pharmacist-license may be issued by the division director upon the approval of the president of the board if an applicant produces satisfactory evidence of fulfilling the requirements for licensure except the examination requirement, and evidence of an emergency situation justifying such temporary license. A. True B. False

Answer: (a) True, [Pharmacy Practice Act of Georgia 26-4-43 and 26-4-44]. A temporary pharmacist-license may be issued by the division director upon the approval of the president of the board if an applicant produces satisfactory evidence of fulfilling the requirements for licensure except the examination requirement, and evidence of an emergency situation justifying such temporary license. All temporary licenses shall expire at the end of the month following the third board meeting conducted after the issuance of such license and may not be reissued or renewed.

An insurance company providing health insurance may offer incentives to pharmacies, pharmacists, and practitioners that accept or utilize electronic data prescription drug orders. A. True B. False

Answer: (a) True, [Pharmacy Practice Act of Georgia 26-4-80(m) and (o)]. Nothing in this Code section shall be construed to prohibit any insurance company, hospital or medical service plan, health care provider network, health maintenance organization, health care plan, employer, or other similar entity providing health insurance from offering incentives to pharmacies, pharmacists, and practitioners that accept or utilize electronic data prescription drug orders. No licensee nor any other entity shall be permitted to provide facsimile machines or equipment, computer software, technology, hardware, or supplies related to the electronic transmission of prescription drug orders to any practitioner which restricts such practitioner from issuing prescription drug orders for certain prescription drugs or restricts a patient from choosing the retail pharmacy to which an electronic prescription drug order may be transmitted.

Under the Georgia State Pharmacy Law, each violation of pertaining to unlawfully engaging in the practice of pharmacy shall also constitute a felony punishable upon conviction thereof by a fine of not less than $500.00 nor more than $1,000.00 or by imprisonment for not less than two nor more than five years, or both. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 26-4-40(c)]. Any individual who, after hearing, shall be found by the board to have unlawfully engaged in the practice of pharmacy shall be subject to a fine to be imposed by the board for each offense. Each violation of this chapter pertaining to unlawfully engaging in the practice of pharmacy shall also constitute a felony punishable upon conviction thereof by a fine of not less than $500.00 nor more than $1,000.00 or by imprisonment for not less than two nor more than five years, or both.

All retail pharmacies shall renew their licenses biennially by June 30th of the odd-numbered years with the Georgia State Board of Pharmacy. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-10-.06(1)(b)(d)]. All retail pharmacies shall renew their licenses biennially by June 30th of the odd-numbered years with the Georgia State Board of Pharmacy. If the application for renewal is not made and the fee paid before September 1st, of the odd numbered year, the license shall lapse and shall not be renewed except by application for a new license.

Pharmacists may compound drugs prior to receiving a valid prescription drug order based on a history of receiving valid prescription drug orders within an established pharmacist/patient/prescriber relationship. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-11-.02(1)(c)]. Pharmacists may compound drugs prior to receiving a valid prescription drug order based on a history of receiving valid prescription drug orders within an established pharmacist/patient/prescriber relationship, and provided that they maintain the prescriptions on file for all such products compounded at the pharmacy. The compounding of inordinate amounts of drugs, relative to the practice site, in anticipation of receiving prescriptions without any historical basis is considered manufacturing which requires a manufacturer’s license.

Only a pharmacy licensed or registered by the Board may distribute compounded preparations to practitioners licensed in this state for administration to their patients in the course of their professional practice, either personally or by an authorized person under their direct and immediate supervision. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-11-.02(2)(a)]. (a). Only a pharmacy licensed or registered by the Board may distribute compounded preparations to practitioners licensed in this state for administration to their patients in the course of their professional practice, either personally or by an authorized person under their direct and immediate supervision. (b). A practitioner shall make a request to the pharmacy for a compounded preparation in the same manner as ordering products from a wholesale pharmaceutical distributor or manufacturer and not by using a prescription drug order. (c). A pharmacy receiving an order from a practitioner for a compounded preparation shall maintain such order with its compounding records as required in Rule 480-11-.08 and other rules and regulations of the Board. (d). Pharmacists shall label all compounded preparations distributed to practitioners for administration to their patients with the following: 1. "By purchase order, Not by prescription", 2. "For Office Use Administration Only - Not for resale", 3. The name of the active ingredients and strengths contained in the compounded preparation, 4. The lot number or identification of the compounded preparation, 5. The pharmacy's name, address and telephone number, 6. The initials of the pharmacist verifying the finished compounded preparation and the date verified, 7. The quantity, amount, size, or weight of the compounded preparation in the container, 8. An appropriate beyond-use (expiration) date of the compounded preparation as determined by the pharmacist in compliance with Board rule and USP-NF standards for pharmacy compounding, and 9. Appropriate ancillary instructions such as storage instructions or cautionary statements, and where appropriate, hazardous drug warning labels.

All pharmacy personnel who engage in the sale or distribution of exempt Schedule V controlled substance containing drug products must complete the DEA’s self-certification training. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-19-.03(a)]. 1). All exempt Schedule V controlled substance pseudoephedrine containing drug products must be stored in a pharmacy’s prescription department. 2). All pharmacy personnel who engage in the sale or distribution of exempt Schedule V controlled substance containing drug products must complete the DEA’s self-certification training as required by the Combat Methamphetamine Epidemic Act of 2005, 21 U.S.C. 830. (b). A registered pharmacist or pharmacy intern or pharmacy extern acting under the direct supervision of a registered pharmacist may sell, dispense or otherwise dispose of without prescription not more than 3.6 grams every 24 hours, or a maximum of 9 grams every 30 days, to each customer of a pseudoephedrine containing drug product, but only: 1). After applying reasonable means or effort to determine that such is to be used for legitimate medical purposes, following the proper record keeping procedures, and ensuring the required information has been properly recorded in a logbook which contains either a written or electronic list of sales.

According to Georgia State Pharmacy Law, a controlled substance prescription drug order issued by an individual practitioner, "For Office Use" to obtain a controlled substance for the purpose of general dispensing or administration to patients in his/her office shall NOT be filled by a pharmacist. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.02(2)]. According to Georgia State Pharmacy Law, a controlled substance prescription drug order issued by an individual practitioner, in his or her name or written "For Office Use" to obtain a controlled substance for the purpose of general dispensing or administration to patients in his/her office shall NOT be filled by a pharmacist. For a controlled substance prescription drug order to be legal, it must be issued for a legitimate medical purpose by an authorized individual practitioner acting in the usual course of his or her professional practice. The responsibility for the proper prescribing of controlled substances is upon the prescribing practitioner, but the pharmacist is responsible for the proper filling of the prescription drug order. Any person knowingly filling a purported prescription drug order, as well as the person issuing it, shall be subject to disciplinary action.

Upon dispensing a schedule II (C-II) drug, a pharmacist shall physically sign his or her name on either the face or rear of the schedule II (C-II) prescription drug order. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.04 (2)]. Upon dispensing a schedule II (C-II) drug, the pharmacist shall physically sign his or her name on either the face or rear of the schedule II (C-II) prescription drug order in such a manner that the signature does not cover any information required by this chapter. In addition, the pharmacist will ensure that the dispensing date and the serial number for the prescription drug order are indicated on either the face or the back of the C-II prescription drug order.

A pharmacist or pharmacy intern/extern may dispense Schedule III, IV and V Controlled Substances pursuant to a facsimile of a written, signed prescription drug order transmitted directly to the pharmacy by the practitioner’s agent. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.07(1)-to-(3) and Pharmacy Practice Act of Georgia 26-4-80(2)(B)]. (1). A pharmacist or pharmacy intern/extern may dispense Schedule III, IV and V Controlled Substances pursuant to: (a). A written prescription drug order bearing the signature of a practitioner as permitted by the law; (b). A facsimile of a written, signed prescription drug order transmitted directly to the pharmacy by the practitioner or the practitioner’s agent; (c). An oral prescription drug order made by an individual practitioner and promptly reduced to writing by the pharmacist or pharmacy intern/extern to a hard copy; and (d). A written prescription drug order transmitted via electronic means other than a facsimile, if it meets the requirements and limitations for electronically transmitted prescription drug orders set forth in the law. Such prescription drug orders must be promptly reduced to hard copy. (2). A pharmacy must either file the original prescription drug order or generate a hard copy prescription drug order to be filled, both of which are required to contain all of the information required by the Georgia Pharmacy Law. __________________________________________________________ [Pharmacy Practice Act of Georgia 26-4-80(2)(B)] (2). Prescription drug orders transmitted by facsimile or computer shall include: (A). In the case of a prescription drug order for a dangerous drug, the complete name and address of the practitioner; (B). In the case of a prescription drug order for a controlled substance, the complete name, address, and DEA registration number of the practitioner; (C). The telephone number of the practitioner for verbal confirmation; (D). The name and address of the patient, unless the prescription drug order is prescribed pursuant to expedited partner therapy for use by a sexual partner of a patient clinically diagnosed with chlamydia or gonorrhea, in which case, the name and address of such sexual partner of the patient; (E). The time and date of the transmission; (F). The full name of the person transmitting the order; and (G). The signature of the practitioner in a manner as defined in regulations promulgated by the board.

Explanation Under a Georgia State Pharmacy Law, a physician’s assistant cannot issue a prescription for any C-III, IV, or V controlled substance without having such prescription co-signed by his or her supervising physician, unless such physician’s assistant has his/her own DEA number. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.12(1)(a)]. A physician’s assistant (PA) licensed by the Georgia Composite Medical Board is permitted to issue a prescription drug order or orders for any dangerous drugs or for any Schedule III, IV, or V controlled substance without the co-signature of a supervising physician under the following conditions: (a). The supervising physician has delegated the authority to prescribe dangerous drugs and/or controlled substances in the PA’s job description on file with the Georgia Composite Medical Board. (b). If the prescription is for controlled substances, the PA has a DEA number. (c). The prescription drug order must be on security paper and include the following: (i). The name, address, and telephone number of the supervising physician and the PA; (ii). The patient’s name and address; (iii). The drug name, strength and quantity prescribed; (iv). The directions to the patient with regard to taking the drug; (v). The number of authorized refills, if any; (vi). A NPI number; and (vii). If applicable, the DEA permit number of the PA. (d). If the prescription is transmitted by facsimile or computer, the prescription shall include: (i). The complete name and address of the supervising physician and the PA; (ii). In the case of a prescription drug order for a controlled substance, the DEA registration number of the PA; (iii). The telephone number of the PA for verbal confirmation; (iv). The name and address of the patient; (v). The time and date of the transmission; (vi). The full name of the person transmitting the order; and (vii). The drug name, strength and quantity prescribed; (viii). The directions to the patient with regard to taking the drug; (ix). The number of authorized refills, if any; (x). A NPI number; and (xi). The signature of the PA or, in the case of a controlled substances prescription, in accordance with 21 C.F.R. 1301.22. (e). No prescription drug order issued by a PA can be used to authorized refills more than twelve (12) months past the date of the original drug order.

The manufacturer of the product is not required to indicate the schedule of the drug on the label of its commercial container if the product is a scheduled drug under the Georgia Controlled Substances Act (GCSA), but not scheduled under the Federal Controlled Substances Act (FCSA). A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.13(1)(a),(b)]. The manufacturer of the product is not required to indicate the schedule of the drug on the label of its commercial container if the product is a scheduled drug under the Georgia Controlled Substances Act (GCSA), but not scheduled under the Federal Controlled Substances Act (FCSA). (1). Any drug scheduled under the Georgia Controlled Substances Act (GCSA), but not scheduled under the Federal Controlled Substances Act (FCSA), must be purchased, stored, inventoried, recorded, distributed, or dispensed in the same manner as any other controlled substance, except: (a). The manufacturer of the product is not required to indicate the schedule of the drug on the label of its commercial container; and (b). The manufacturer of the product is not required to print the symbol designating the schedule of the drug on the label of its commercial container. (2). A prescription drug order for any drug scheduled under the GCSA, but not scheduled under the Federal CSA, must be maintained in the same manner for the corresponding controlled substance prescription drug order as previously set forth in this chapter (480-22).

Any drug scheduled under the Georgia Controlled Substances Act (GCSA), but not scheduled under the Federal Controlled Substances Act (FCSA), must be purchased, stored, inventoried, recorded, distributed, or dispensed in the same manner as any other controlled substances. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.13]. Any drug scheduled under the Georgia Controlled Substances Act (GCSA), but not scheduled under the Federal Controlled Substances Act (FCSA), must be purchased, stored, inventoried, recorded, distributed, or dispensed in the same manner as any other controlled substances, EXCEPT: (a). The manufacturer of the product is not required to indicate the schedule of the drug on the label of its commercial container; (b). The manufacturer of the product is not required to print the symbol designating the schedule of the drug on the label of its commercial container. (2). A prescription drug order for any drug scheduled under the GCSA, but not scheduled under the Federal CSA, must be maintained in the same manner for the corresponding controlled substance prescription drug order under GCSA.

Ophthalmic topical products may be refilled without authorization from a practitioner. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-22-.15]. Ophthalmic topical products may be refilled without authorization from a practitioner to prevent unintended interruptions in drug therapy provided that: (1). The original prescription order contains valid refills; (2). Refills occur at 70 percent or greater of the predicted days of use; and (3). Refills are purchased through retail and/or mail order pharmacies.

Once a multi-drug single-dosing container has been properly labeled and dispensed to a patient, and this same container is returned to the pharmacy, the drugs packaged in such container are considered adulterated and may not be returned to the pharmacy stock. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy 480-9-.03(e)(1)-to-(4),(f)]. Once a multi-drug single-dosing container has been properly labeled and dispensed to a patient, and this same container is returned to the pharmacy, the drugs packaged in such container are considered adulterated and may not be returned to the pharmacy stock. Drugs may be redispensed only under the following conditions: 1. Drugs repackaged for and redispensed only to the same patient to whom the drugs were originally dispensed or; 2. Whenever a patient has an allergic reaction to any drug contained in a multi-drug single-dosing container and this drug is discontinued from the patient’s treatment, a pharmacy cannot repackage and redispense any drug(s) that were packaged with the discontinued drug in the single-dosing container, because any such drug is then considered to be adulterated. 3. Unopened unit-dose drugs packaged only by the original drug manufacturer dispensed to and returned only by a Long Term Care facility patient for Medicaid credit; 4. A multi-drug single-dosing container must be tampered evident in such a manner to prevent the container from being re-closed or designed to show evidence of having been opened. Whenever a drug(s) in such a container previously dispensed to a patient has/have been discontinued, the remaining container(s) must be returned to the dispensing pharmacy for the removal of the discontinued drug(s) from the container for destruction. Except as provided for in paragraph 480-9-.03(5)(a)1, once the discontinued drug(s) has/have been removed, the pharmacy may repackage the drug(s) to be continued and once again only dispense them to the patient to whom they were originally dispensed. Under no circumstances may any of the remaining or discontinued drug(s) be returned to the drug stock of the pharmacy or dispensed to any patient other than the patient to whom the drugs were originally dispensed, as specified in 480-9-.03(5), (6) and (7).

A hard copy prescription prepared by a practitioner or a practitioner's agent and printed on security paper, which bears an electronic visual image of the practitioner's signature is considered a valid prescription. A. True B. False

Answer: (a) True, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 5, 26-4-80 (c)]. A prescription drug order may be accepted by a pharmacist or pharmacy intern or extern in written form, orally, via an electronic visual image prescription drug order, or via an electronic data prescription drug order as set forth in this chapter or as set forth in regulations promulgated by the board. Electronic prescription drug orders shall either be an electronic visual image of a prescription drug order or an electronic data prescription drug order and shall meet the requirements set forth in regulations promulgated by the board.

Please select minimum equipment(s)/reference(s) require(s) to operate a retail pharmacy. a. Georgia Pharmacy Practice Act b. Refrigerator in operating condition with a thermometer c. Class A Balance d. Two mortars and pestles of assorted sizes e. Minimum two pill counting trays f. Two spatulas A. a, b, c, d, and f B. b, d and f C. a, c, d and e D. All

Answer: (a) a, b, c, d, and f [Rules of Georgia State Board of Pharmacy 480-10-.12 and 480-13-.05]. No pharmacy licensed in Georgia, shall engage in the practice of filling, compounding or dispensing prescriptions unless it shall possess the following items: (a). Copies of and/or computer or electronic access to current reference materials appropriate to the individual pharmacy practice. These reference materials shall be authoritative on at least the topics of drug interactions; patient counseling; compounding and pharmaceutical calculations; and generic substitution. (b). The telephone number of a poison control center. This number shall be conspicuously posted within the prescription department. (c). Current copies of and/or computer or electronic access to the following: 1. Georgia Pharmacy Practice Act 2. Georgia Controlled Substances Act and Dangerous Drug Act and 3. Official Rules of the Georgia State Board of Pharmacy. 4. Copies of and/or electronic or computer access to current reference materials appropriate to the practice of the hospital pharmacy (Only for Hospital Pharmacy); 5. Copy of and/or electronic or computer access to the latest edition of the American Society of Health-system Pharmacists Formulary Service (Only for Hospital Pharmacy); 6. Compatibility charts; (Only for Hospital Pharmacy); 7. Current drug interaction references; (Only for Hospital Pharmacy); 8. Current antidote information; (Only for Hospital Pharmacy); 9. Copy of and/or electronic access or computer access to the latest edition of text and reference works covering theoretical and practical pharmacy, reference materials on general, organic, pharmaceutical and biological chemistry, toxicology, pharmacology, sterilization and disinfection. (Only for Hospital Pharmacy); (d). Equipment (appliances): 1. Refrigerator in operating condition with a thermometer; and 2. Sink in working condition with both hot and cold running water. (e). Weighing and labeling: 1. Class A Balance, Class I or II Electronic Balance, or as approved in writing by the Board; 2. Assortment of weights: metric and apothecary, only if utilizing a Class A Balance; 3. Appropriate prescription labels consistent with the requirements of the Georgia Drug and Cosmetic Act, and 4. Appropriate auxiliary labels that should be used in the pharmacist’s professional judgment. (f). Other equipment: 1. Graduates of assorted sizes; 2. Two mortars and pestles of assorted sizes; 3. Two spatulas; 4. One pill counting tray (NOT two); 5. Ointment slab, tile or ointment paper pad; 6. Stirring rods; 7. Typewriter, word processor or computer with label-printer; and 8. Any other equipment necessary for a specialized practice setting where such a specialized practice takes place. 9. Laminar flow hood; (Only for Hospital Pharmacy); 10. Facility for light-dark field examination. (Only for Hospital Pharmacy);

A 45-year-old patient comes to the pharmacy and presents a prescription for Zolpidem written by his podiatrist. A pharmacist shall: A. not fill the prescription. B. fill the prescription. C. ask the patient to get a new prescription from an authorized prescriber. D. fill and dispense the prescription after filling out a DEA 222 order form.

Answer: (a) shall not fill the prescription, [Rules of Georgia State Board of Pharmacy 480-22-.02(a)]. For a controlled substance prescription drug order to be legal, it must be issued for a legitimate medical purpose by an authorized individual practitioner acting in the usual course of his or her professional practice. The responsibility for the proper prescribing of controlled substances is upon the prescribing practitioner, but the pharmacist is responsible for the proper filling of the prescription drug order. A registered physician, dentist, veterinarian, or podiatrist authorized by this state to prescribe controlled substances can issue a prescription for controlled substances only in the usual course of his or her professional practice. Therefore, a pharmacist shall question the prescription for sleeping pill (Zolpidem) prescribed by a registered podiatrist.

All prescriptions may be transmitted electronically from an originating pharmacy to a central fill pharmacy including via facsimile. All transmission records must include: [ Select All That Apply]. A. "Central Fill" written on the face of a prescription if it is a hard copy prescription. B. The name, address and telephone number of the central fill pharmacy. C. The name of the originating pharmacy pharmacist transmitting the prescription. D. Number of refills already dispensed.

Answer: (a,b,c,d) All, [GA Rule 480-10A-.05. Transmission and Labeling]. (1). The transmission and labeling of controlled substance prescriptions processed utilizing central fill services must comply with all federal and state laws, rules, and regulations. (2). The originating pharmacy must comply with the minimum required information for the patient record system and all requirements of a prescription drug order as outlined in the Georgia law and Board rules prior to sending a prescription to the central fill pharmacy. (3). All prescriptions may be transmitted electronically from an originating pharmacy to a central fill pharmacy including via facsimile. (4). All transmission records must include the following: (a). “CENTRAL FILL†written on the face of a prescription if it is a hard copy prescription, (b). The name, address, telephone number, Georgia license number, and DEA registration number (if the prescription is a controlled substance), of the central fill pharmacy to which the prescription has been transmitted, (c). Number of refills already dispensed and number of refills remaining (if applicable), (d). The name of the originating pharmacy pharmacist transmitting the prescription, and (e). The date of transmittal. (5). All receipt of transmission records must include all information included in subsection 4 and the name, address, telephone number, Georgia license number, and DEA registration number (if the prescription is a controlled substance), of the originating pharmacy transmitting the prescription.

An advertisement of a drug, device, or cosmetic shall be deemed to be completely false (in pharmacies) if the advertisement of a drug or device representing it to have any effect in: [Select ALL THAT APPLY]. A. cancer B. measles C. diabetes D. high blood pressure

Answer: (a,b,c,d) [GA Law 26-3-13. When advertisements of drugs or cosmetics deemed false]. (a) An advertisement of a drug, device, or cosmetic shall be deemed to be completely false if it is false or misleading in any particular. (b). For the purpose of this chapter the advertisement of a drug or device representing it to have any effect in albuminuria, appendicitis, arteriosclerosis, blood poisoning, bone disease, Bright's disease, cancer, carbuncles, cholecystitis, diabetes, diphtheria, dropsy, erysipelas, gallstones, heart and vascular diseases, high blood pressure, mastoiditis, measles, meningitis, mumps, nephritis, otitis media, paralysis, pneumonia, poliomyelitis or infantile paralysis, prostate gland disorders, pyelitis, scarlet fever, sexual impotence, sinus infection, smallpox, tuberculosis, tumors, typhoid, uremia, or sexually transmitted disease shall also be deemed to be false, except: that no advertisement not in violation of subsection (a) of this Code section shall be deemed to be false under this subsection if it is disseminated only to members of the medical, dental, or veterinary professions, appears only in the scientific periodicals of these professions, or is disseminated only for the purpose of public health education by persons not commercially interested directly or indirectly in the sale of such drugs or devices, provided that whenever the State Board of Pharmacy determines that an advance in medical science has made any type of self-medication safe as to any of the diseases named in this subsection, the board shall by regulation authorize the advertisement of drugs having curative or therapeutic effect for such disease subject to such conditions and restrictions as the board may deem necessary in the interest of public health, provided that this subsection shall not be construed as indicating that self-medication for diseases other than those named herein is safe or efficacious.

When compounding preparations for distributing to veterinarian for administration, which of the following classes of schedule controlled substance prescription requires a patient specific prescription drug order? [Select All That Apply]. A. Schedule II B. Schedule III C. Schedule IV D. Schedule V

Answer: (a,b,c,d) [GA Rule 480-11-.02 Compound Drug Preparations]. Pharmacists may not compound Schedule II, III, IV or V controlled substances, for distributing to veterinarian for administration, without a patient specific prescription drug order.

Pharmacists shall label all compounded preparations distributed to veterinarian for administration or emergency dispensing to their patients with: [ Select All That Apply]. A. By purchase order, Not by prescription. B. For Office Use Administration. C. The pharmacy's name, address and telephone number. D. The initials of the dispensing pharmacist.

Answer: (a,b,c,d) [GA Rule 480-11-.02. Compound Drug Preparations]. (a). Only a pharmacy licensed or registered by the Board may distribute compounded preparations to veterinarians licensed in this state for administration or emergency dispensing to their patients in the course of their professional practice, either personally or by an authorized person under their direct and immediate supervision. (b). A veterinarian shall make a request to the pharmacy for a compounded preparation in the same manner as ordering products from a wholesale pharmaceutical distributor or manufacturer and not by using a prescription drug order. (c). A pharmacy receiving an order from a veterinarian for a compounded preparation shall maintain such order with its compounding records as required in Rule 480-11-.08 and other rules and regulations of the Board. (d). Pharmacists shall label all compounded preparations distributed to veterinarian for administration or emergency dispensing to their patients with the following: 1. “By purchase order, Not by prescriptionâ€, 2. “For Office Use Administration or Emergency Dispensing by a Veterinarian Only - Not for resaleâ€, 3. The name of the active ingredients and strengths contained in the compounded preparation, 4. The lot number or identification of the compounded preparation, 5. The pharmacy's name, address and telephone number, 6. The initials of the pharmacist verifying the finished compounded preparation and the date verified, 7. The quantity, amount, size, or weight of the compounded preparation in the container, 8. An appropriate beyond-use (expiration) date of the compounded preparation as determined by the pharmacist in compliance with Board rule and USP-NF standards for pharmacy compounding, and 9. Appropriate ancillary instructions such as storage instructions or cautionary statements, and where appropriate, hazardous drug warning labels. “Emergency Dispensing†shall mean no more than a 96 hour supply dispensed for an urgent condition to an animal patient by a licensed veterinarian with a valid veterinarian-client-patient relationship when timely access to a compounding pharmacy is not available.

The label affixed to the container of a prescription drug filled by a central fill pharmacy must contain: [ Select All That Apply]. A. The originating pharmacy name, address, and telephone number. B. The central fill pharmacy name, address, and telephone number. C. The name of the prescribing practitioner. D. The name of the patient.

Answer: (a,c,d) [GA Rule 480-10A-.05(6). Transmission and Labeling]. (6). The label affixed to the container of a dangerous drug or other non-controlled substance filled by a central fill pharmacy must contain the following: (a). Date of fill or refill, (b). The originating pharmacy name, address, and telephone number, (c). The central fill pharmacy's unique identifier, (d). The serial number of the prescription, (e). The name of the patient, (f). The name of the prescribing practitioner, (g) Name of supervising physician if applicable, (h) Expiration date of the dispensed drug, and (i) The directions for use and cautionary statements, if any, contained in such prescription or required by law.

A patient brings a new prescription for Alprazolam with 5 eligible refills. The prescription is written on April 1, 2020. The prescription reads: Alprazolam 1 mg: 1 tablet by mouth at bed time x 30 days. Refills: 5 times A patient has requested medication to be partially filled. Below is the list of partially filled transactions: 1. 04/04/2020: 20 tablets 2. 05/05/2020: 40 tablets 3. 05/25/2020: 18 tablets 4. 06/09/2020: 23 tablets 5. 06/21/2020: 5 tablets 6. 08/11/2020: 35 tablets 7. 09/05/2020: 11 tablets 8. 10/11/2020: 36 tablets 9. 10/28/2020: 21 tablets 10. 11/05/2020: 6 tablets Based on above information what shall be the dispensed quantities (legally)? A. 180 tablets B. 152 tablets C. 150 tablets D. Cannot be partially filled.

Answer: (b) 152 tablets, [Rules of Georgia State Board of Pharmacy 480-22-.09]. Partial refills of schedules III and IV controlled substance prescriptions are permissible under Georgia regulations provided that each partial filling is dispensed and recorded in the same manner as a refilling (i.e., date refilled, amount dispensed, initials of dispensing pharmacist, etc.), the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed, and no dispensing occurs after six months past the date of issue. In above example, the prescription expires on 10/01/2020 (six months from an issue date of 04/01/2020). Therefore, all partial filling before this date should be considered legal. The second thing the pharmacist has to observe that the total quantity dispensed in all partial fillings shall not exceed the total quantity prescribed. The prescription is written for 180 tablets, 1 tablet by mouth qd x 30 days with additional 5 refills. When adding all the partial filling starting from 04/04/2020 to 09/05/2020, the total quantities that the pharmacist can dispense legally come about 152 tablets.

What is the acceptable pharmacist to pharmacy technician ratio for a retail pharmacy in Georgia? A. 1:2 B. 1:3 C. 1:4 D. No restriction

Answer: (b) 1:3, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, 26-4-82(d)]. The board of pharmacy shall promulgate rules and regulations regarding the activities and utilization of pharmacy technicians in pharmacies. The pharmacist to pharmacy technician ratio shall not exceed one pharmacist providing direct supervision of three pharmacy technicians. The board may consider and approve an application to increase the ratio in a pharmacy located in a licensed hospital. Such application must be made in writing and must be submitted to the board by the pharmacist in charge of a specific hospital pharmacy in this state. One of the three technicians must: (1). Have successfully passed a certification program approved by the board of pharmacy; OR (2). Have successfully passed an employer's training and assessment program which has been approved by the board of pharmacy; OR (3). Have been certified by either the Pharmacy Technician Certification Board or any other nationally recognized certifying body approved by the board of pharmacy.

In Georgia, a prescription for Fioricet can be refilled how many times? A. Cannot be refilled B. 5 times C. As Needed within 1-year D. Maximum 10 times

Answer: (b) 5 times, [http://www.nascsa.org/stateprofiles/georgia.htm]. Normally for most states Fioricet is a non-controlled substance whereas Fiorinal is a controlled substance. However, in Georgia, all Butalbitals, including those in combination with acetaminophen or aspirin, are classified as Schedule III controlled substance. Therefore, the prescription for Fioricet in Georgia can be filled maximum 5 times within a 6-month period.

What is the maximum amount of Robitussin A/C that can be dispensed to a given purchaser within a 48-hour period? A. 240 cc B. 120 cc C. 60 cc D. 480 cc

Answer: (b) According to Georgia Pharmacy Law, not more than a 4 ounce or 32 dosage units of an exempted Schedule V controlled substance over-the-counter preparation containing Schedule V controlled substances can be dispensed to a given purchaser within a 48-hour period, [Rules of Georgia State Board of Pharmacy 480-19-.01(b)].

In Georgia, inventory records must be maintained for a period of at least: A. 1 year B. 2 years C. 3 years D. 4 years

Answer: (b) According to Georgia State Pharmacy Law, an inventory records must be maintained for a period of at least two years, [Controlled Substance Act of Georgia 16-13-39 and 21CFR1304.04(a)]. Rule 16-13-39: Persons registered to manufacture, distribute, or dispense controlled substances under this article shall keep a complete and accurate record of all controlled substances on hand, received, manufactured, sold, dispensed, or otherwise disposed of and shall maintain such records and inventories in conformance with the record-keeping and inventory requirements of federal law and with any rules issued by the State Board of Pharmacy.

Narcotic Treatment Program Clinic Pharmacy must meet the requirements set by: A. GDNA B. DBHDD C. DEA D. CSA

Answer: (b) DBHDD, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, 26-4-5 Definition (23.5)]. "Narcotic Treatment Program Clinic Pharmacy" means a pharmacy which is attached to, located in, or otherwise a part of and operated by a narcotic treatment program which provides an opiate replacement treatment program, as designated or defined by the Department of Behavioral Health and Developmental Disabilities (DBHDD) or such other state agency as may be designated as the state authority for the purposes of implementing the narcotic treatment program authorized by federal and state laws and regulations.

Who shall administer PDMP in Georgia? A. Georgia Bureau of Investigation B. Department of Public Health C. Georgia State Pharmacy Board D. Georgia Composite Medical Board

Answer: (b) Department of Public Health [GA Law 16-13-57 Creation of monitoring program]. The department shall, in consultation with members of the Georgia Composite Medical Board, the State Board of Pharmacy, and the agency, establish and maintain a program to electronically record into an electronic PDMP prescription information resulting from the dispensing of Schedule II, III, IV, or V controlled substances and to electronically review such prescription information that has been entered into such data base. The purpose of such PDMP shall be to assist in the reduction of the abuse of controlled substances; to improve, enhance, and encourage a better quality of health care by promoting the proper use of medications to treat pain and terminal illness; to reduce duplicative prescribing and overprescribing of controlled substance practices for health oversight purposes; and to gather data for epidemiological research. The PDMP shall be administered by the department. Each prescriber who has a DEA registration number shall enroll to become a user of the PDMP as soon as possible, and no later than January 1, 2018; provided, however, that prescribers who attain a DEA registration number after such date shall enroll within 30 days of attaining such credentials. A prescriber who violates this subsection shall be held administratively accountable to the state regulatory board governing such prescriber for such violation.

A pharmacist receives a new prescription from a prescriber for compounding a cream that is commercially available. What shall pharmacist do? A. Fill the prescription. B. Do not fill the prescription.

Answer: (b) Do not fill the prescription, [Rules of Georgia State Board of Pharmacy 480-11-.02(1)(a) and FDA Compliance Policy Guide Sec. 460.200 Pharmacy Compounding]. Based on the existence of a pharmacist/patient/prescriber relationship and the presentation of a valid prescription drug order or in anticipation of a prescription drug order based on routine, regularly observed prescribing patterns, pharmacists may compound, for an individual patient, drug preparations that are commercially or not commercially available in the marketplace. Pharmacists may compound drugs prior to receiving a valid prescription drug order based on a history of receiving valid prescription drug orders within an established pharmacist/patient/prescriber relationship, and provided that they maintain the prescriptions on file for all such preparations compounded at the pharmacy. The compounding of inordinate amounts of drugs, relative to the practice site, in anticipation of receiving prescriptions without any historical basis is considered manufacturing which requires a manufacturer’s license. The distribution of compounded preparations without a prescriber/patient/pharmacist relationship is considered manufacturing. Pharmacists shall not offer compounded drugs to other state-licensed persons or commercial entities for subsequent resale. Pharmacists shall not engage in the following: (a). The compounding for human use of a pharmaceutical product that has been withdrawn or removed from the market by the FDA because such drug product or a component of such drug product has been found to be unsafe. (b). The compounding of any pharmaceutical products that are essentially copies of commercially available pharmaceutical products. However, this prohibition shall not include: 1. The compounding of any commercially available product when there is a change in the product ordered by the prescriber for an individual patient, 2. The compounding of a commercially available manufactured pharmaceutical during times when the product is not available from the manufacturer or wholesale distributor, 3. The compounding of a commercially manufactured pharmaceutical that appears on the drug shortages list, or 4. The mixing of two or more commercially available products of which the end product is a commercially available product.

How often shall clean rooms and laminar flow hoods be certified? A. Every 3 months B. Every 6 months C. Every 12 months D. Monthly

Answer: (b) Every 6 months, [Rules of Georgia State Board of Pharmacy 480-11-.09(1)(a)]. All clean rooms, ante rooms, barrier isolators and laminar flow hoods shall be certified following procedures such as those outlined in the CETA Certification Guide for Sterile Compounding Facilities (CAG-003-2005) should be performed by a qualified individual no less than every six months whenever the device or room is relocated, altered, or major service to the facility is performed. Appropriate documentation and records shall be maintained.

In order to prevent unintended interruptions in drug therapy for topical ophthalmic products, a pharmacist shall be authorized, without obtaining subsequent authorization from the practitioner or obtaining a new prescription from the practitioner, to permit refills at 50 percent of the predicted days of use. A. True B. False

Answer: (b) False, [GA Law 26-4-80 (f)(2)]. In order to prevent unintended interruptions in drug therapy for topical ophthalmic products: (A). A pharmacist shall be authorized, without obtaining subsequent authorization from the practitioner or obtaining a new prescription from the practitioner, to permit refills at 70 percent of the predicted days of use; and (B). At the patient's request, a practitioner shall be permitted to authorize refills earlier than 70 percent of the predicted days of use. This paragraph shall apply to refills purchased through retail pharmacies and mail order sources.

A pharmacist shall require a person picking up a controlled substance prescription to present a government issued photo identification document or such other form of identification which documents legibly the full name of the person taking possession of the controlled substance. A. True B. False

Answer: (b) False, [GA Law 26-4-80 (l)]. A pharmacist shall require a person picking up a Schedule II controlled substance prescription (Schedule III, IV or V can be dispensed without an id) to present a government issued photo identification document or such other form of identification which documents legibly the full name of the person taking possession of the Schedule II controlled substance.

The central fill pharmacy shall be responsible for maintaining compliance with the Prescription Drug Monitoring Program for all qualifying prescriptions. A. True B. False

Answer: (b) False, [GA Rule 480-10A-.06. Information Systems, Record Keeping, and PDMP Compliance]. (1). The originating and central fill pharmacies must share common electronic files or have appropriate technology to allow secure access to sufficient information necessary or required to process and dispense the prescription. (2). The originating pharmacy (not the central fill pharmacy) shall be responsible for maintaining compliance with the Prescription Drug Monitoring Program for all qualifying prescriptions pursuant to O.C.G.A. § 16-13-59 including those filled utilizing central fill services. (3). The record keeping of prescriptions processed utilizing central fill services must comply with all federal and state laws, rules, and regulations. (4). The originating pharmacy must have a pharmacist, pharmacy intern, pharmacy extern, or pharmacy technician sign for the receipt of all prescriptions received from the central fill pharmacy. (a). Such receipts must be maintained as a part of the prescription record. Receipts shall include the date of receipt, the method of delivery (private, common, or contract carrier) and the name of the originating pharmacy employee accepting delivery. (b). The pharmacist on duty at the originating pharmacy must verify the receipt of all controlled substances. (5). The originating pharmacy is responsible for maintaining records of the processing of all prescriptions entered into their information system including prescriptions filled at a central fill pharmacy. (a). The information system must have the ability to audit the activities of the individuals at the central fill pharmacy filling the originating pharmacy's prescriptions.

In Georgia, the distribution of non-patient specific compounded preparations for office use by a practitioner is valid as long as the compounded drug products administered by the practitioner to his/her patients. A. True B. False

Answer: (b) False, [GA Rule 480-11-.02 Compound Drug Preparations]. (1). Compounded drug preparations - Pharmacist/Patient/Prescriber Relationship. (a). Based on the existence of a pharmacist/patient/prescriber relationship and the presentation of a valid prescription drug order or in anticipation of a prescription drug order based on routine, regularly observed prescribing patterns, pharmacists may compound, for an individual patient, drug preparations that are not commercially available in the marketplace or commercially available in the place as outlined by the restrictions under 12(b). Dispensing of pharmaceutical products shall be consistent with the provisions of O.C.G.A. T. 16, Ch. 13 and T. 26, Ch. 4 relating to the issuance of prescriptions and the dispensing of drugs. (b). Pharmacists shall receive, store, or use pharmaceuticals that have been manufactured or repackaged in a FDA-registered facility. Pharmacists shall also receive, store, or use pharmaceuticals in compounding preparations that meet official compendia requirements. If neither of these requirements can be met, pharmacists shall use their professional judgment to procure alternatives. (c). Pharmacists may compound pharmaceuticals prior to receiving a valid prescription drug order based on a history of receiving valid prescription drug orders within an established pharmacist/patient/prescriber relationship, and provided that they maintain the prescriptions on file for all such preparations compounded at the pharmacy. Preparations compounded in anticipation of a valid prescription drug order shall be properly labeled to include the name of the compounded pharmaceutical, date of compounding, and beyond-use date. (d). The distribution of non-patient specific compounded preparations for office use by a practitioner, excluding veterinarians, is prohibited. This subsection shall not affect 503b outsourcing facilities ability to provide non-patient specific compounded preparations for office use by a practitioner. The distribution of compounded preparations, for office administration or emergency dispensing, to a veterinarian shall not exceed 5% of production of compounded preparation in a calendar year by that pharmacy. Amounts produced greater than 5% shall be considered manufacturing and will require separate licensure as a manufacturer.

A prescription becomes invalid after the practitioner and patient relationship is terminated which is defined as a reasonable period of time not to exceed three months in which the patient could have established a new practitioner and patient relationship as established by the board. A. True B. False

Answer: (b) False, [Pharmacy Practice Act of Georgia 26-4-80(h)]. When the patient no longer seeks personal consultation or treatment from the practitioner, the practitioner and patient relationship is terminated. A prescription becomes invalid after the practitioner and patient relationship is terminated which is defined as a reasonable period of time not to exceed six months (NOT three months) in which the patient could have established a new practitioner and patient relationship as established by the board.

A hard copy of an electronic data prescription drug order for any Schedule II controlled substance that is given directly to the patient shall NOT be REQUIRED on security paper approved by the board. A. True B. False

Answer: (b) False, [Pharmacy Practice Act of Georgia 26-4-80.1(c)]. If a hard copy of an electronic data prescription drug order for any Schedule II controlled substance is given directly to the patient, the manually signed hard copy prescription drug order must be on security paper approved by the board.

According to Georgia State Pharmacy Law, a pharmacist in charge of a pharmacy cannot supervise more than two pharmacies at one time. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-10-.02(3)]. A licensed pharmacist shall be in charge of each pharmacy. His or her name shall be upon the application for the license of the pharmacy; he or she shall be the pharmacist in charge of and have supervision of not more than one pharmacy at one time; and he or she shall be responsible for the conduction of business related to prescriptions within and access to said retail pharmacy. This regulation is not intended to prohibit any pharmacist from engaging in the practice of pharmacy at more than one pharmacy. This regulation does not prohibit a pharmacist from being in charge of one separately licensed Home Health Care Pharmacy and/or one Nursing Home Pharmacy, and/or one Long Term Health Care Facility Pharmacy in addition to being in charge of a retail pharmacy as long as each pharmacy is operated under the same ownership and is located under the same roof, provided that there is a physical separation of the two pharmacies and separate inventories are maintained for the two pharmacies.

In the case of multiple retail pharmacies being operated by a parent corporation, each individual pharmacy must get an approval from the Board regarding security system to be used by all pharmacies operated by that corporation. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-10-.16(6)]. In the case of multiple retail pharmacies being operated by a parent corporation, the parent corporation may submit a request for a blanket approval of the same security system to be used by all pharmacies operated by that corporation. A copy of the written Board approval and the system description must be maintained at each pharmacy operated by the corporation. Thereafter, any new pharmacy operated by that corporation may utilize the same security system which was previously approved by the Board.

An authorized nurse practitioner may, when drugs or controlled substances are not otherwise available from a licensed pharmacy, dispense an emergency amount of medication, but only sufficient quantities until such time as medication can be obtained from a pharmacy licensed as a retail pharmacy. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-13-.06(11)]. An authorized practitioner (Nurses are not allowed) may, when drugs or controlled substances are not otherwise available from a licensed pharmacy, dispense an emergency amount of medication, but only sufficient quantities until such time as medication can be obtained from a pharmacy licensed as a retail pharmacy. Nurses or other unauthorized personnel may NOT dispense medication from the emergency room. The total act of dispensing shall be performed by an authorized practitioner in accordance with Pharmacy Laws, Rules and Regulations. Such medications shall be labeled as required in Section 480-13-.06(3)(b).

Pharmacy X receives a prescription for Methyldopa, which is forwarded to a pharmacy Y because of back order of the drug. The act done by the pharmacy X is in accordance with the law. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-16-.02(1)(a)]. Once a pharmacy receives a patient’s prescription drug order, that pharmacy cannot forward such prescription drug order to a second pharmacy in order for the second pharmacy to fill the prescription drug order and return the filled drug container to the original pharmacy for dispensing or delivery to the patient. Since a pharmacy or a pharmacist is NOT a physician or an agent of physician. The solution to this is Pharmacy X shall enter a prescription in a computer data system and then transfer it to the pharmacy y for filling it.

Stolen, lost, or unaccounted for controlled substances must, within ten (10) days of discovery, be reported to the Drug Enforcement Administration and the GDNA. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-16-.06(1),(2),(3)]. Stolen, lost, or unaccounted for controlled substances must, within THREE (3) days of discovery, be reported to the Drug Enforcement Administration and the GDNA. (2). A written report must be made regarding any theft, loss or unaccounted for controlled substances by completing a DEA Form 106. Within ten (10) days of receiving such DEA Form 106, the original and one copy of the report must be sent to the Drug Enforcement Administration; and one copy must be sent to the GDNA.

Practitioners not registered with the DEA, but affiliated with hospitals or other institutions (DEA registered) cannot prescribe controlled substances. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-22-.03(4)(a),(b)]. Practitioners not registered with the DEA, but affiliated with hospitals or other institutions, shall include the registration number of the hospital or other institutions as well as the special internal code assigned to the authorized practitioner by the hospital or other institution, as provided for in federal regulations 21 CFR 1301.22(c), in lieu of a DEA registration when prescribing or issuing a controlled substance drug order. Each such hand written prescription drug order shall meet the requirements of Rule 480-22-.04 and shall have the name of the practitioner stamped, typed or hand printed on it, as well as the signature of the practitioner, along with the telephone number where the practitioner can be contacted for verification. Such prescription drug orders can only be issued by such practitioner for patients treated as a part of his/her duties at such hospital or other institution.

A patient record shall be maintained for a period of not less than five years from the date of the last entry in the profile record. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-27-.09(3) AND Pharmacy Practice Act of Georgia 26-4-83(b,d) And Rules of Georgia State Board of Pharmacy 480-31-.01(3)]. A patient record system shall be maintained by all pharmacies for patients for whom prescription drug orders are dispensed. The patient record system shall provide for the immediate retrieval of information necessary by the pharmacist to identify previously dispensed drugs at the time a prescription drug order is presented for dispensing. The pharmacist or the pharmacist's designee shall make a reasonable effort to obtain, record, and maintain the following information: (1). The full name of the patient for whom the drug is intended; (2). The address and telephone number of the patient; (3). The date of birth of the patient; and (4). The gender of the patient. (c). The pharmacist shall make a reasonable effort to obtain from the patient or the patient's agent and shall record any known allergies, drug reactions, idiosyncrasies, and chronic conditions or disease states of the patient and identify any other drugs, including over-the-counter drugs or devices, currently being used by the patient which may relate to prospective drug use review unless the patient or the patient's agent refuses to provide such information. A patient record shall be maintained for a period of not less than two years** from the date of the last entry in the profile record. **Conflict Information with Rules of Georgia State Board of Pharmacy 480-27-.09(3) : A patient record shall be maintained for a period of not less than five years from the date of the last entry in the profile record. This record may be a hard copy or a computerized form. **

The total quantity of drugs dispensed by using Multi-drug Single-dosing containers may not be more than a seven day supply. A. True B. False

Answer: (b) False, [Rules of Georgia State Board of Pharmacy 480-9-.03(a),(b),(c)]. The conditions for allowing Multi-drug Single-dosing containers shall be as follows: (a). The number of drugs placed in one package cannot exceed the capacity of the container in order to prevent damage to the individual dosage forms; (b). The total quantity of drugs dispensed may not be more than a thirty-four (34) (NOT seven days) day supply; (c). The labels must be of sufficient size to properly and clearly label each container of a thirty-four (34) days or less drug supply with all information required by state and federal law and rules.

Who shall be informed when unusual orders of controlled substances are received by the registrant? A. FDA B. GDNA C. DEA D. Georgia State Pharmacy Board

Answer: (b) GDNA. Each registrant shall maintain records of unusual orders of controlled substances received by the registrant and shall inform the Office Director of the Georgia Drugs and Narcotics Agency (GDNA) of unusual orders when discovered by the registrant, [Rules of Georgia State Board of Pharmacy 480-20-.02(1)]. For purposes of this section, an unusual order shall include orders of greatly increased quantity, orders deviating substantially from a normal pattern, and orders of highly abnormal frequency.

Which of the following is/are TRUE in regard to pharmacists compounding sterile drugs to be provided to practitioners to use in patient care? I. Such sterile compounding shall only be conducted as allowed by board rule for pharmaceutical compounding using USP-NF standards for sterile compounding. II. Such sterile drugs may be compounded only in quantities determined by board rule following consultation with the Georgia Composite Medical Board. III. Only Schedule II controlled drug cannot be compounded to be provided to practitioners to use in patient care. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II are true, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 5, 26-4-86(c)]. In regard to pharmacists compounding sterile drugs to be provided to practitioners to use in patient care or altering or repackaging such drugs for practitioners to use in patient care in the practitioner's office: 1. Such sterile compounding shall only be conducted as allowed by applicable federal law and board rule for pharmaceutical compounding using USP-NF standards for sterile compounding. 2. Such sterile drugs may be compounded only in quantities determined by board rule following consultation with the Georgia Composite Medical Board. 3. No Schedule II, III, IV, or V controlled substance shall be eligible for such designation. Nothing in this subsection shall be construed to apply to pharmacies owned or operated by institutions or to pharmacists or practitioners within or employed by an institution or affiliated entity; provided, however, that pharmacies owned or operated by institutions and pharmacists and practitioners within or employed by institutions or affiliated entities shall remain subject to other rules and regulations established by the board governing the compounding of medication.

A pharmacist may, in the exercise of his or her professional judgment and in consultation with the patient, dispense up to a 90 day supply of maintenance medication for treatment of chronic illnesses up to the total number of dosage units as authorized by the prescriber on the prescription, including any refills, unless: I. The prescriber has specified on the prescription that concurrently dispensing initial amounts and refills of such maintenance medication is not allowed. II. It is the initial filling of a prescription for a new maintenance medication or dosage for the patient. III. The prescription is for a schedule II controlled substance; schedule III, IV or V can be filled. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [GA Law 26-4-80 (q)]. A pharmacist may, in the exercise of his or her professional judgment and in consultation with the patient, dispense up to a 90 day supply of maintenance medication for treatment of chronic illnesses up to the total number of dosage units as authorized by the prescriber on the prescription, including any refills, unless: 1. The prescriber has specified on the prescription that concurrently dispensing initial amounts and refills of such maintenance medication is not allowed. OR 2. It is the initial filling of a prescription for a new maintenance medication or dosage for the patient. Schedule II, III, IV, or V controlled substances are not allowed.

Which of the following statements are TRUE regarding a pharmacist's absence from a pharmacy? I. Such times when the pharmacist is absent from the pharmacy cannot exceed three (3) hours daily, or more than one and one half (1-1/2) hours at any one time. II. In the absence of a pharmacist from the pharmacy, the area designated as the prescription department shall be closed and locked in such a manner as to prevent unauthorized entry. III. No prescriptions shall be filled, compounded, dropped off or dispensed in the absence of a licensed pharmacist. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-10-.02(4)(a)(1)-to-(3)]. Such times when the pharmacist is absent from the pharmacy cannot exceed three (3) hours daily, or more than one and one half (1-1/2) hours at any one time. Whenever the pharmacist is absent from the pharmacy, a sign shall be prominently displayed on the entrance to the prescription department announcing, “Prescription Department Closed†and such sign shall be clear and legible with letters not less than three (3) inches in size. In the absence of a pharmacist from the pharmacy, the area designated as the prescription department shall be closed and locked in such a manner as to prevent unauthorized entry. No prescriptions shall be filled, compounded, or dispensed in the absence of a licensed pharmacist, but prescriptions may be dropped off by patients provided there is a “drop box†which can only be accessed by a licensed pharmacist.

Which of the following statements are TRUE regarding a specialty pharmacy practice under a Georgia State Pharmacy Law? I. In order to qualify for specialty pharmacy practice certification, the applicant must be a pharmacist currently licensed and in good standing with the State of Georgia, and pass an examination approved by the Board in the specific area of specialty practice. II. A person who has already passed the examination and meets all requirements may make application to the Board on a form approved by the Board and pay the fee in the amount provided in the Board’s fee schedule. III. Licensed pharmacists who have a specialty pharmacy practice certification must complete a minimum of twenty (20) hours of continuing education in each specific area of specialty during each biennium renewal period. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-12-.01, 480-12-.02 and 480-12-.03]. (1). The Georgia State Board of Pharmacy (“Boardâ€) has the authority to approve accreditation or certification programs for specialty pharmacy practice, included, but not limited to: (a). Diabetes; (b). Dyslipidemia; (c). Asthma; and (d). Anticoagulation In order to qualify for specialty pharmacy practice certification, the applicant must be a pharmacist currently licensed and in good standing with the State of Georgia, and pass an examination approved by the Board in the specific area of specialty practice. A person who has already passed the examination and meets all requirements may make application to the Board on a form approved by the Board and pay the fee in the amount provided in the Board’s fee schedule. (2). The board has approved the Disease State Management Examinations of the National Association of Boards of Pharmacy, or its successor organization. (3). Licensed pharmacists who have a specialty pharmacy practice certification must complete a minimum of TEN (10) hours (not 20 hours) of continuing education in each specific area of specialty during each biennium renewal period. The hours obtained herein may be used to fulfill the continuing education requirements.

In order to be registered as a Pharmacy Technician in this State, an applicant shall: I. Submit an application to the Board on the form prescribed by the Board. II. Attest that applicant is currently enrolled in high school, or has a high school diploma, or has a GED. III. Attest that applicant is at least 21 years old. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-15-.02(b)]. (a). Effective August 1, 2011, a pharmacy may only employ registered pharmacy technicians to perform pharmacy technician duties. (b). In order to be registered as a Pharmacy Technician in this State, an applicant shall: (1). Submit an application to the Board on the form prescribed by the Board; (2). Attest that applicant is at least 17 years (not 21 years) old; (3). Attest that applicant is currently enrolled in high school, or has a high school diploma, or has a GED, or has a postsecondary education or college degree; (4). Consent to, provide the necessary information to conduct, and pay for a background check to be conducted by the Board, its agent or a firm or firms approved by the Board, which background check will include a criminal history, driver license history and other information as the Board deems necessary, and will authorize the Board and the Georgia Drugs and Narcotics Agency to receive the results; (5). Submit the name and address of employer and place of employment; (6). Pay application fees; and (7). If certified, submit evidence of training supporting designation as certified. (e). A registration, once issued, is renewable biennially, upon payment of a fee. Registrations shall expire on June 30th of each odd-numbered year. If the application for renewal is not made and the fee paid before September 1st of the odd-numbered year, the registration shall lapse and shall not be renewed. An application for a new registration shall be required. (f). A registrant has a responsibility to update the Board with a change of home address and employment address within ten (10) days of such change.

Which of the following statements are TRUE regarding drugs included in (opioid treatment program) emergency kits/crash carts? I. A listing of the drugs contained including name, strength, quantity, and expiration date of the contents shall be attached to the exterior of emergency carts. II. Drugs shall be removed from emergency kits/crash carts only pursuant to a valid practitioner’s order, by authorized personnel, or by a pharmacist of the institutional facility. III. Each emergency kit/crash cart shall be opened and its contents inspected by a pharmacist at least once every thirty (30) days. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-18-.04(3)]. The exterior of emergency kits/crash carts shall be labeled so as to clearly and unmistakably indicate that it is an emergency drug kit/crash cart and is for use in emergencies only. In addition, a listing of the drugs contained therein, including name, strength, quantity, and expiration date of the contents shall be attached. All drugs contained in emergency kits/crash carts shall be labeled in accordance with such State and Federal Laws and Regulations which pertain thereto; and shall also be labeled with such other and further information as may be required by the medical staff of the hospital to prevent misunderstanding or risk of harm to the patients; (f). Removal of drugs. Drugs shall be removed from emergency kits/crash carts only pursuant to a valid practitioner’s order, by authorized personnel, or by a pharmacist of the institutional facility; (g). Notification. Whenever an emergency kit/crash cart is opened, the pharmacy shall be notified; and pharmacy personnel shall restock and re-seal the kit/cart within a reasonable time so as to prevent risk of harm to patients. In the event the kit/cart is opened in an unauthorized manner, the pharmacy and other appropriate personnel of the facility shall be notified; (h). Inspections. Each emergency kit/crash cart shall be opened and its contents inspected by a pharmacist at least once every NINETY (90) days. Upon completion of inspection, the emergency kit/crash cart shall be re-sealed.

Which of the following statements are TRUE regarding continuing education requirements under Georgia State Pharmacy Law? I. Each pharmacist in the State of Georgia must obtain 3 C.E.U.’s per biennium for license renewal. II. Each approved provider of continuing education in the State of Georgia shall provide a means of registration of the participants at each program and a record of attendance shall be maintained for a period of five years. III. Each licensed pharmacist shall maintain these certificates of attendance at continuing education meetings for a period of three years from the date of the preceding renewal period. A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-3-.03]. Each pharmacist in the State of Georgia must obtain 30 hours of continuing education or 3.0 C.E.U.’s per biennium for license renewal. Each continuing education program must be approved by ACPE. Each approved provider of continuing education in the State of Georgia shall provide a means of registration of the participants at each program and a record of attendance shall be maintained for a period of five (5) years. Each licensed pharmacist shall maintain these certificates of attendance at continuing education meetings for a period of TWO years from the date of the preceding renewal period. The following are not acceptable as continuing educations programs: welcoming remarks, business sessions, unstructured demonstrations, degree programs, or medical continuing education programs which are not A.C.P.E. or Georgia Board approved.

No pharmacist shall be authorized to modify drug therapy unless that pharmacist: I. Is licensed to practice as a pharmacist in the state. II. Has successfully completed a course of study regarding modification of drug therapy. III. Annually successfully completes a 6-contact hours continuing education program regarding modification of drug therapy. A. I only B. I and II only C. All D. Pharmacist cannot modify drug therapy.

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-35-.02, 480-35-.03 And Pharmacy Practice Act of Georgia 26-4-50(a),(b)]. (1). A pharmacist may apply to the Board for a certification which will allow the pharmacist to enter into a protocol or agreement with a physician for drug therapy modification. Each application shall be reviewed by the Board for completeness and authenticity before certification can be issued. Such application shall include, but is not limited to: (a). Completion of an application form approved by the Board to include at a minimum: (i). Name, home address, telephone number, and email address (if applicable); (ii). Georgia pharmacist license number, including any previous sanctions by the Board or any other actions by a licensing or criminal authority; and (iii). Current place of practice setting, including name, address, and telephone number and place where the protocol and patient records will be maintained. (b). Submission of an application fee approved by the Board; (c). Submission of evidence of completion of a course of study, approved by the Board, related to drug therapy modification; and (d). Submission of evidence of 0.3 continuing education units (CEUs) or 3.0 contact hours in courses related to drug therapy modification. Such CEUs must be obtained during the 12 months prior to submitting the application. (2). A certification authorizing drug therapy modification must be renewed by December 31st of each year. A certification authorizing drug therapy modification not renewed by December 31st shall expire. (3). In order to renew a certification, a pharmacist must apply to the Board on an application form approved by the Board, submit a renewal fee, and submit evidence of 0.3 CEUs or 3 contact hours (Not 6 contact hours) in continuing education courses obtained annually and approved by the Board or the Accreditation Council for Pharmacy Education (ACPE). In order to renew a certification under this chapter, the continuing education must: (1). Be from a provider approved by the Board pursuant to Rule 480-3-.03 or a provider approved by ACPE. (2). Have been taken and credit received for the continuing education during the 12 months preceding the application for renewal. (3). Have been from a live program at least 1.0 contact hour (0.1 CEU) in length. (4). Have been on the topic of the therapy area in which the Pharmacist seeks to make drug therapy modifications The current certification must be posted with the pharmacist's license.

A patient requests that a pharmacy dispense medication in a multi-drug single-dosing container that has been previously labeled and dispensed by another pharmacy. Under these circumstances, which of the following statements may be TRUE? I. The pharmacy must first receive written permission from the patient or the patient’s caregiver. II. Whenever a pharmacy receives a written request to redispense drugs in a multi-drug single-dosing container, and such drugs have been previously dispensed by another pharmacy, the pharmacy choosing to redispense must maintain a redispensing log using the pre-established record-keeping guidelines. III. All redispensing logs, statements, and other such records are required to be maintained by the pharmacy for a minimum of three years. A. I only B. I and II only C. All D. Cannot be redispensed.

Answer: (b) I and II only, [Rules of Georgia State Board of Pharmacy 480-9-.04(a),(b),(c)]. The pharmacy must first receive written permission from the patient or the patient’s caregiver. Whenever a pharmacy receives a written request to redispense drugs in a multi-drug single-dosing container, and such drugs have been previously dispensed by another pharmacy, the pharmacy choosing to redispense must maintain a redispensing log using the pre-established record-keeping guidelines. For each drug redispensed, this log must include at a minimum: 1. The name, address, and telephone number of the redispensing pharmacy; 2. The date the drug was redispensed; 3. The name and address of the patient; 4. The serial number on the label of the originally dispensed prescription drug container; 5. The name, address, and telephone number of the pharmacy originally dispensing the drug; 6. The serial number assigned to the drug by the redispensing pharmacy; 7. The name, quantity, and identifying logo or numbers of the drug as it was originally dispensed and is now being redispensed; 8. The expiration date assigned to the drug being redispensed, with such date being no longer than one (1) year from the date of redispensing; 9. The name of the prescribing practitioner; 10. The directions for administration or taking as written by the prescribing physician; 11. Any special labeling information or instructions; 12. The name or initials of the pharmacist verifying the redispensed drug against the log and/or the original drug container; All redispensing logs, statements, and other such records are required to be maintained by the pharmacy for a minimum of TWO years.

What information shall be required on the face of the CII prescription, issued for a terminally ill patient, transmitted via facsimile machine by the prescribing practitioner's agent? I. The name of the prescribing practitioner's agent II. The telephone number of the prescribing practitioner III. The special internal code of the prescribing practitioner's agent A. I only B. I and II only C. II and III only D. All

Answer: (b) I and II, [Rules of Georgia State Board of Pharmacy 480-22-.04(4)]. A prescription drug order for a terminally ill patient written for a Schedule II Controlled Substance may be transmitted directly by the practitioner or the practitioner’s agent to the dispensing pharmacy by facsimile machine. (a). Prior to the prescribing practitioner’s agent transmitting such Schedule II Controlled Substance prescription via facsimile machine, i. the name of the agent and ii. a telephone number for the prescribing practitioner must be included in the face of prescription. The information may be used for verification of the prescription. (b). The facsimile serves as the original, written prescription drug order for purposes of this paragraph. After transmission of the original prescription, the pharmacist should suggest that the practitioner mark "VOID" across the face of the prescription, and that it be maintained by the practitioner in the patient’s medical record chart.

Which of the following statements are TRUE about furnishing samples of dangerous controlled substances to the prescriber? I. A manufacturer's sales representative may distribute a dangerous drug as a complimentary sample upon the written or verbal request of a practitioner. II. The written request shall be preserved by the manufacturer for a period of five years. III. The request must be made for each distribution and shall contain the names and addresses of the supplier and the requestor and the name and quantity of the specific dangerous drug requested. A. I only B. III only C. II and III only D. All

Answer: (b) III only, [Controlled Substance Act of Georgia 16-13-72(5)]. A manufacturer’s sales representative may distribute a dangerous drug as a complimentary sample only upon the WRITTEN request of a practitioner. The request must be made for each distribution and shall contain the names and addresses of the supplier and the requestor and the name and quantity of the specific dangerous drug requested. The written request shall be preserved by the manufacturer for a period of TWO years.

The Marco home infusion clinic has provided fax machines and computers to the physician’s office of Dr. RJ. The act done by the clinic is in accordance with Georgia State Pharmacy Law. A. Yes B. No

Answer: (b) No, [Pharmacy Practice Act of Georgia 26-4-80(m)]. Under Georgia State Pharmacy Law, no licensee nor any other entity shall be permitted to provide facsimile machines or equipment, computer software, technology, hardware, or supplies related to the electronic transmission of prescription drug orders to any practitioner which restricts such practitioner from issuing prescription drug orders for certain prescription drugs or restricts a patient from choosing the retail pharmacy to which an electronic prescription drug order may be transmitted.

A pharmacist is adding 1000 mg of pure codeine powder to 100 cc of Tylenol with codeine Elixir (120 mg/12 mg/5 cc). The resultant mixture should be classified as: A. Schedule II B. Schedule III C. Schedule IV D. Schedule V

Answer: (b) The compounded mixture should be classified as a Schedule III controlled drug, [Controlled Substance Act of Georgia 16-13-27(4)(B)]. The amount of Codeine present in the final mixture is 1.24 gms (1000 mg plus 240 mg). It has been stated under CSA that if a mixture contains less than 1.8 gms of Codeine per 100 cc, it should be classified as a Schedule III controlled substance. List of Schedule III controlled drugs: ______________________________ Ketamine (Only under Rules of Georgia State Board of Pharmacy 480-34-.02] Sodium oxybate (Xyrem) (Only under Rules of Georgia State Board of Pharmacy 480-34-.03] Tiletamine/Zolazepam (Telazol) Amobarbital and noncontrolled active ingredients Amobarbital suppository dosage form Anabolic steroids Barbituric acid derivative Benzphetamine (Didrex, Inapetyl) Buprenorphine (Buprenex, Temgesic) Butabarbital (Butisol, Butibel) Butalbital (Fiorinal, Butalbital with aspirin) Codeine and isoquinoline alkaloid (Codeine with papaverine or noscapine) Codeine combination product (Empirin, Fiorinal, Tylenol, ASA or APAP w/codeine) Dronabinol in sesame oil in soft gelatin capsule (Marinol) Lysergic acid Lysergic acid amide Methyltestosterone (Android, Oreton, Testred, Virilon) Nalorphine (Nalline) Nandrolone (Deca-Durabolin, Durabolin, Durabolin-50) Norethandrolone(Nilevar, Solevar) Opium combination product (Paregoric) Pentobarbital and noncontrolled active ingredients Pentobarbital suppository dosage form Phendimetrazine (Bontril) Secobarbital and noncontrolled active ingredients Secobarbital suppository dosage form Testosterone (Android-T, Androlan, Depotest, Delatestryl) Thiopental (Pentothal)

In the case of unauthorized refills, the dispensed quantity of the refilled non-controlled drug should be limited to a: A. One-day supply B. Seven-day supply C. Three-day supply D. Thirty-day supply

Answer: (c) 72 hour supply of a prescribed medication, [Pharmacy Practice Act of Georgia 26-4-80(j)]. A pharmacist licensed by the board may dispense up to a 72 hour supply of a prescribed medication in the event the pharmacist is unable to contact the practitioner to obtain refill authorization provided that: (1). The prescription is not for a controlled substance; (2). In the pharmacist's professional judgment, the interruption of therapy might reasonably produce undesirable health consequences or may cause physical or mental discomfort; (3). The dispensing pharmacist notifies the practitioner or his or her agent of the dispensing within 7 working days after the prescription is refilled pursuant to this subsection; (4). The pharmacist properly records the dispensing as a separate nonrefillable prescription. Said document shall be filed as is required of all other prescription records. This document shall be serially numbered and contain all information required of other prescriptions. In addition it shall contain the number of the prescription from which it was refilled; (5). The pharmacist shall record on the patient's record and on the new document the circumstances which warrant such dispensing; and (6). The pharmacist does not employ this provision regularly for the same patient on the same medication.

A pharmacist steps out to answer the question of a patient regarding selecting proper OTC drugs for her diarrhea. A physician calls in for a new prescription during this time, and the prescription is taken by registered intern. Which of the following can be true? A. A registered intern is allowed to take a verbal order from the physician. B. A registered intern shall take the order but hand it to the pharmacist as soon as possible. C. A registered intern shall not take the prescription order. D. A registered intern with special license can take a verbal order from the physician.

Answer: (c) A registered intern shall not take the prescription order, [Pharmacy Practice Act of Georgia 26-4-82(b)]. For all prescriptions it shall be the responsibility of the pharmacist on duty at a facility to ensure that only a pharmacist or a pharmacy intern under the direct supervision of a pharmacist provides professional consultation and counseling with patients or other licensed health care professionals, and that only a pharmacist or a pharmacy intern under the direct supervision of a pharmacist accepts initial telephoned prescription orders or provides information in any manner relative to prescriptions or prescription drugs. In this case, the pharmacist is temporarily absent and the pharmacist intern is not under direct supervision of the pharmacist at the time of taking a verbal order from the physician. Therefore, the correct choice should be "A registered intern shall not take the prescription order".

Before an out-patient prescription drug is released from the dispensing area, the prescription drug shall bear a label containing: I. the name and address of the pharmacy. II. the name of the patient. III. the initials or identifying code of the dispensing pharmacist. A. I only B. I and II only C. All D. Does not require labeling.

Answer: (c) All, [Pharmacy Practice Act of Georgia 26-4-80(k)]. All out-patient prescription drug orders which are dispensed shall be appropriately labeled in accordance with the rules and regulations promulgated by the board as follows: (1). Before an out-patient prescription drug is released from the dispensing area, the prescription drug shall bear a label containing the name and address of the pharmacy, a prescription number, the name of the prescriber, the name of the patient, directions for taking the medication, the date of the filling or refilling of the prescription, the initials or identifying code of the dispensing pharmacist, and any other information which is necessary, required, or, in the pharmacist's professional judgment, appropriate; and (2). The pharmacist who fills an out-patient prescription drug order shall indicate the identity of the dispensing pharmacist on the label of the prescription drug. Identification may be made by placing initials on the label of the dispensed drug. The label shall be affixed to the outside of the container of the dispensed drug by means of adhesive or tape or any other means which will assure that the label remains attached to the container.

Which of the following occurrence(s) require(s) immediate notification to the Board at its address of record? I. Thefts or break-ins at the licensed pharmacy. II. Change of location of a licensed pharmacy. III. Change in management of a licensed pharmacy. A. I only B. I and II only C. All D. None of the above require immediate notification.

Answer: (c) All, [Rules of Georgia State Board of Pharmacy 480-10-.20(2)]. The following occurrences require immediate notification to the Board at its address of record, unless otherwise provided: (a). Permanent closing of a licensed pharmacy. Notification shall include the name and contact information for the person responsible for maintaining the pharmacy records after the pharmacy has closed and location of the records. (b). Change of ownership or location of a licensed pharmacy. Since a pharmacy license cannot be transferable, unless such change has been previously approved by the Board following the submission of the appropriate applications, the existing pharmacy license is void and there is no continuing authority to operate as a pharmacy. (c). Change in management of a licensed pharmacy. (d). Change of the pharmacist in charge of a licensed pharmacy. When the Board receives notice that a pharmacy no longer has a pharmacist in charge and no replacement pharmacist in charge is named, the pharmacy's license is suspended pending further action by the Board. (e). Any theft or loss of drugs or devices of a licensed pharmacy. This notification must also be made to the Georgia Drugs and Narcotics Agency, and if involving controlled substances, the pharmacy must comply with Rule 480-16-.06. (f). Any known conviction of any employee of a licensed pharmacy of any state or federal drug laws, not previously reported. (g). Disasters or accidents involving the licensed pharmacy. (h). Thefts or break-ins at the licensed pharmacy. (i). Theft, destruction, or loss of records of a licensed pharmacy required to be maintained by state or federal law. (j). Occurrence at a licensed pharmacy of a significant adverse drug reaction by a customer or person receiving medication dispensed or compounded by the licensed pharmacy.

A pharmacist receive a new non-electronic prescription for Synthroid from a prescriber. The prescription is stamped with "Brand Medically Necessary". Which of the following is TRUE? A. Fill the prescription for Synthroid. B. Fill the prescription for Levothyroxine. C. Call and verify with the physician. D. Fill the prescription for either one.

Answer: (c) Call and verify with the physician, [Pharmacy Practice Act of Georgia 26-4-81(g)]. A prescribing practitioner may specify in writing or by a telephonic or other electronic communication that there shall be no substitution for the specified brand name drug product in any prescription, provided that the phrase "BRAND MEDICALLY NECESSARY", shall be in the practitioner's HANDWRITING on the prescription form or on an electronically-produced copy of the prescription form or, if the prohibition was communicated by telephonic or other electronic communication that did not reproduce the practitioner's handwriting, a statement to that effect appears on the form. The phrase "BRAND MEDICALLY NECESSARY" shall NOT be preprinted or stamped or initialed on the form. When the prescription is an electronic prescription drug order, the words "brand necessary" are not required to be in the practitioner's own handwriting and may be included on the prescription in any manner or by any method. When a practitioner has designated "brand necessary" on an electronic prescription drug order, a generic drug shall not be substituted without the practitioner's express consent, which shall be documented by the pharmacist on the prescription and by the practitioner in the patient's medical record.

Which of the following is/are TRUE regarding the theft, loss, or unaccounted controlled substances? I. The theft, loss, or unaccounted for controlled substances must be reported to the Drug Enforcement Administration and the GDNA within seven (7) days of its discovery. II. A written report must be made regarding any theft, loss or unaccounted for controlled substances by completing a DEA Form 106. III. Within ten (10) days of receiving such DEA Form 106, the original and one copy of the report must be sent to the Drug Enforcement Administration; and one copy must be sent to the GDNA. A. I only B. I and II only C. II and III only D. All

Answer: (c) II and III are true, [Rules of Georgia State Board of Pharmacy 480-16-.06(1),(2),(3)]. The theft, loss, or unaccounted for controlled substances must be reported to the Drug Enforcement Administration and the GDNA within three (3) days of its discovery. (2). A written report must be made regarding any theft, loss or unaccounted for controlled substances by completing a DEA Form 106. (a). Within ten (10) days of receiving such DEA Form 106, the original and one copy of the report must be sent to the Drug Enforcement Administration; and one copy must be sent to the Georgia Drugs and Narcotics Agency (GDNA). (3). The report shall include the following information: _____________________________________________ (a). Full name and address of the pharmacy; (b). Pharmacy DEA registration number; (c). Date of theft, loss, or discovery of missing controlled substance; (d). Type of incident, i.e. theft, loss, etc.; (e). List of cost codes, or identification symbols on package stolen; and (f). List of the controlled substances missing.

It is unlawful for any person, other than a retail distributor, to knowingly possess any product that contains ephedrine, pseudoephedrine, or phenylpropanolamine in an amount which exceeds: I. 100 tablets II. 300 gelcaps III. 9 grams A. I only B. I and II only C. II and III only D. All

Answer: (c) II and III, [Rules of Georgia State Board of Pharmacy Title 16, 16-13-30.3(b)(1)]. It is unlawful for any person, other than a retail distributor, to knowingly possess any product that contains ephedrine, pseudoephedrine, or phenylpropanolamine in an amount which exceeds 300 pills, tablets, gelcaps, capsules, or other individual units OR More than 9 grams of ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers, or a combination of any of these substances, whichever is smaller.

Which of the following information about temporary absences of a licensed pharmacist in a pharmacy? I. Law prohibits such temporary absences. II. Such temporary absences shall NOT exceed 3 hours per day. III. Such temporary absences shall NOT exceed one and one-half hours at any given time. A. I only B. None of the above C. II and III only D. All

Answer: (c) II and III, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 5, 26-4-110(i)]. During hours of operation, every pharmacy licensed pursuant to this chapter shall have a prescription department under the personal supervision of a duly licensed pharmacist who shall have personal supervision of not more than one pharmacy at the same time, provided that nothing in this chapter shall be construed to prohibit any pharmacist from having personal supervision of a pharmacy located in a hospital, nursing home, college of pharmacy, or a pharmacy owned and operated directly by a health maintenance organization. Every pharmacy licensed, except those located within and owned and operated by a duly licensed and accredited hospital, nursing home, or college of pharmacy, shall have a prescription department open for business at all times that the business establishment is open to the public, except that during temporary absences of any licensed pharmacist not to exceed three hours daily or more than one and one-half hours at any one time the prescription department shall be closed and no prescription shall be filled or dispensed.

A 32-year-old patient comes to the pharmacy with a prescription for MS Contin. Upon examining the prescription, the pharmacist notices that the prescriber forget to include the quantity to be dispensed. A pharmacist may: I. contact and speak with an agent for the practitioner if the prescriber is absent. II. send back the prescription to the prescriber’s office to correct it. III. write the missing quantity of the prescribed drug on the face of the prescription along with the initials of the pharmacist after the missing information provided by the prescriber. A. I only B. I and II only C. III only D. II and III only

Answer: (c) III only, [Rules of Georgia State Board of Pharmacy 480-22-.04(8)(a)-to-(d)]. Whenever a pharmacist receives a prescription for a C-II controlled substance, and either the quantity of the drug to be dispensed or the strength of the drug to be dispensed has not been included by the prescribing practitioner, or when the strength of the prescribed drug is not immediately available, in order to dispense this drug, the pharmacist must perform the following: (a). Contact and speak directly with the practitioner, not with an agent for the practitioner, and inform the practitioner of the missing information on the face of the prescription, or the problem with the prescription in question by: 1. Determining the quantity of the drug the practitioner intended to be dispensed; or 2. Determining the strength of the drug the practitioner intended to be dispensed; or 3. Informing the practitioner the drug in the strength prescribed is not immediately available, but another strength of the prescribed drug is available. (b). Regarding the information provided by the practitioner, the pharmacist must write the missing quantity, the missing strength, or the changed quantity and strength of the prescribed drug on the face of the prescription along with the initials of the pharmacist. (c). On the back of the prescription, the pharmacist must write the date and time the pharmacist spoke with the practitioner, along with a brief explanation of the situation and how it was resolved.

Which of the following is/are classified as Schedule II controlled drug(s)? I. Heroin II. Morphine III. Pentobarbital A. I only B. I and II only C. II and III only D. All

Answer: (c) Morphine sulfate and Pentobarbital are classified as Schedule II controlled drugs, [Controlled Substance Act of Georgia 16-13-25 and 16-13-26]. Heroin is classified as a Schedule I controlled drug. List of Schedule II controlled drugs: _____________________________ Alfentanil (Alfenta) Amobarbital(Amytal, Tuinal) Amphetamine (Dexedrine, Biphetamine) Coca Leaves Cocaine Codeine Dextropropoxyphene, bulk (non-dosage forms) Dihydrocodeine (Didrate, Parzone) Diphenoxylate Diprenorphine Ecgonine (Cocaine precursor, in Coca leaves) Ethylmorphine (Dionin) Fentanyl (Innovar, Sublimaze, Duragesic) Glutethimide (Doriden, Dorimide) Hydrocodone (dihydrocodeinone) Hydrocodone and isoquinoline alkaloid Hydrocodone combination product (Tussionex, Tussend, Lortab, Vicodin, Hycodan, Anexsia) Hydromorphone (Dilaudid, dihydromorphinone) Levo-alphacetylmethadol (LAAM, long acting methadone, levomethadyl acetate) Meperidine (Demerol, Mepergan, pethidine) Methadone (Dolophine, Methadose, Amidone) Methamphetamine (Desoxyn, D-desoxyephedrine, ICE, Crank, Speed) Methylphenidate (Ritalin) Morphine (MS Contin, Roxanol, Duramorph, RMS, MSIR) Opium poppy Opium tincture Opium, granulated Opium, powdered Opium, raw Oxycodone (OxyContin, Percocet, Tylox, Roxicodone, Roxicet) Oxymorphone (Numorphan) Pentobarbital (Nembutal) Poppy Straw Concentrate Remifentanil (Ultiva) Secobarbital (Seconal, Tuinal) Sufentanil (Sufenta)

What maximum number of tablets, each containing 30 mg Pseudoephedrine HCl, can be sold OTC within 24-hour time frame to each customer? A. 50 tablets B. 19 tablets C. 77 tablets D. 146 tablets

Answer: (d) 146 tablets, [Rules of Georgia State Board of Pharmacy 480-19-.03(b)(4)]. A registered pharmacist or pharmacy intern or pharmacy extern acting under the direct supervision of a registered pharmacist may sell, dispense or otherwise dispose of without prescription not more than 3.6 grams every 24 hours, or a maximum of 9 grams every 30 days, to each customer of a pseudoephedrine containing drug product. The quantities of different strengths pseudoephedrine containing drug products that equal 3.6 grams are: 1. 30 mg Pseudoephedrine HCl (146 Tablets) 2. 60 mg Pseudoephedrine HCl (73 Tablets) 3. 120 mg Pseudoephedrine HCl (36 Tablets) 4. 30 mg Pseudoephedrine Sulfate (155 Tablets) 5. 60 mg Pseudoephedrine Sulfate (77 Tablets) 6. 120 mg Pseudoephedrine Sulfate (38 Tablets) 7. 240 mg Pseudoephedrine Sulfate (19 Tablets)

Which of the following is/are classified as Schedule IV controlled drug(s)? I. Oxazepam II. Zaleplon III. Butorphanol A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Controlled Substance Act of Georgia 16-13-28]. List of Schedule IV controlled drugs: ______________________________ Carisoprodol (Soma) Tramadol (Ultram) Alprazolam (Xanax) Barbital(Barbitone) Butorphanol (Stadol, Stadol NS, Torbugesic, Torbutrol) Chloral hydrate (Noctec) Chlordiazepoxide (Librium, Libritabs, Limbitrol, SK-Lygen) Clonazepam (Klonopin, Clonopin) Clorazepate(Tranxene) Dexfenfluramine (Redux) Propoxyphene dosage forms with other ingredients (Darvon, Darvocet, Dolene, Propacet) Diazepam (Valium, Valrelease) Dichloralphenazone (Midrin) Difenoxin 1 mg/ Atropine 25 mcg (Motofen) Estazolam (ProSom, Domnamid, Eurodin, Nuctalon) Ethchlorvynol (Placidyl) Fenfluramine (Pondimin, Ponderal) Flurazepam (Dalmane) Lorazepam (Ativan) Mazindol (Sanorex, Mazanor) Meprobamate (Miltown, Equanil, Deprol, Equagesic, Meprospan) Midazolam (Versed) Modafinil (Provigil) Oxazepam (Serax, Serenid-D) Pemoline (Cylert) Pentazocine (Talwin, Talwin NX, Talacen, Talwin Compound) Phenobarbital (Luminal, Donnatal, Bellergal-S) Phentermine (Ionamin, Fastin, Adipex-P, Obe-Nix, Zantryl) Prazepam (Centrax) Quazepam (Doral, Dormalin) Sibutramine (Meridia) Temazepam (Restoril) Triazolam (Halcion) Zaleplon (Sonata) Zolpidem (Ambien) Zopiclone (Lunesta)

Any officer or employee of the State Board of Pharmacy designated by the director of the Georgia Drugs and Narcotics Agency may: I. Carry firearms in the performance of his official duties. II. Execute and serve search warrants, arrest warrants, administrative inspection warrants, subpoenas, and summonses issued under the authority of this state. III. Make arrests without warrant for any offense committed in his presence or if he has probable cause to believe that the person to be arrested has committed or is committing a violation of law, which may constitute a felony. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Controlled Substance Act of Georgia 16-13-45(1)-to(5)]. Any officer or employee of the State Board of Pharmacy designated by the director of the Georgia Drugs and Narcotics Agency may: (1). Carry firearms in the performance of his official duties; (2). Execute and serve search warrants, arrest warrants, administrative inspection warrants, subpoenas, and summonses issued under the authority of this state; (3). Make arrests without warrant for any offense under this article committed in his presence or if he has probable cause to believe that the person to be arrested has committed or is committing a violation of this article, which may constitute a felony; (4). Make seizures of property pursuant to this article; or (5). Perform other law enforcement duties as the State Board of Pharmacy or the director of the Georgia Drugs and Narcotics Agency designates.

A registered licensed professional nurse who is employed or engaged by a licensed home health agency may possess: I. sterile water II. sterile saline III. diluted heparin A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Georgia Controlled Substance Act 16-13-72(4.2)]. A licensed registered professional nurse who is employed or engaged by a licensed home health agency may possess sterile saline, sterile water, and diluted heparin for use as intravenous maintenance for use in a home health setting, and such nurse may administer such items to patients of the home health agency upon the order of a licensed physician. The State Board of Pharmacy shall be authorized to adopt regulations governing the storage, quantity, use, and administration of such items; provided, however, nothing in this paragraph or in such regulations shall be construed to restrict any authority of nurses existing under other provisions of law.

The board shall be notified immediately upon the occurrence of which of the following: I. Permanent closing of a licensed pharmacy. II. Any theft or loss of drugs or devices of a licensed pharmacy. III. Occurrence at a licensed pharmacy of a significant adverse drug reaction as defined by rules of the board. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-112]. The board shall be notified immediately upon the occurrence of any of the following: (1). Permanent closing of a licensed pharmacy; (2). Change of ownership, management, or location of a licensed pharmacy; (3). Change of the pharmacist in charge of a licensed pharmacy; (4). Any theft or loss of drugs or devices of a licensed pharmacy; (5). Any known conviction of any employee of a licensed pharmacy of any state or federal drug laws; (6). Disasters, accidents, theft, destruction, or loss of records of a licensed pharmacy required to be maintained by state or federal law; (7). Occurrence at a licensed pharmacy of a significant adverse drug reaction as defined by rules of the board; (8). Any and all other matters and occurrences at a licensed pharmacy as the board may require by rule.

Which of the following statements are TRUE about issuing a dangerous or controlled substance to an emergency service provider? I. The medical director of an emergency service provider and the issuing pharmacy must have a signed contract or agreement designating the issuing pharmacy as the provider of drugs and consultant services. II. A written record of all drugs issued to the medical director of an emergency service provider must be maintained by the issuing pharmacy and emergency service provider. III. To provide for the proper control and accountability of drugs, a written record of all drugs used by such emergency service provider shall be provided to the issuing pharmacy within 72 hours of use. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-116(a)-to-(g)]. (a). Dangerous drugs and controlled substances shall only be issued to the medical director of an emergency service provider from pharmacies licensed in this state only in accordance with the provisions of this Code section. (b). The medical director of an emergency service provider and an issuing pharmacy must have a signed contract or agreement designating such pharmacy as a provider of drugs and consultant services and a copy must be filed with the state board and the Department of Public Health prior to any drugs being issued. (c). A manual of policies and procedures for the handling, storage, labeling, and record keeping of all drugs must be written, approved, and signed by the medical director of an emergency service provider and the pharmacist in charge of an issuing pharmacy. The manual shall contain procedures for the safe and effective use of drugs from acquisition to final disposition. (d). A written record of all drugs issued to the medical director of an emergency service provider must be maintained by the issuing pharmacy and emergency service provider. Agents of the Georgia Drugs and Narcotics Agency may review all records to determine the accuracy and proper accountability for the use of all drugs. (e). To provide for the proper control and accountability of drugs, a written record of all drugs used by such emergency service provider shall be provided to the issuing pharmacy within 72 hours of use. (f). A pharmacist from a contracting issuing pharmacy shall physically inspect the drugs of such emergency service provider to determine compliance with appropriate policies and procedures for the handling, storage, labeling, and record keeping of all drugs not less than annually and maintain records of such inspection for a period of not less than two years. Such an inspection shall, at a minimum, verify that: (1). Drugs are properly stored, especially those requiring special storage conditions; (2). Drugs are properly accounted for by personnel of such emergency service provider; (3). Proper security measures to prohibit unauthorized access to the drugs are implemented; and (4). All policies and procedures are followed and enforced. (g). All outdated, expired, unused, or unusable drugs shall be returned to the issuing pharmacy for proper disposition in a manner acceptable to the board.

Drug Regimen Review includes which of the following? I. Duplication of therapy II. Drug-drug interactions III. Known allergies A. I only B. III only C. I and II only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-5(13) And Rules of Georgia State Board of Pharmacy 480-11-.01(14)]. Drug regimen review includes but is not limited to the following activities: (A). Evaluation of any prescription drug order and patient record for: (i). Known allergies; (ii). Rational therapy-contraindications; (iii). Reasonable dose and route of administration; and (iv). Reasonable directions for use; (B). Evaluation of any prescription drug order and patient record for duplication of therapy; (C). Evaluation of any prescription drug order and patient record for the following interactions: (i). Drug-drug; (ii). Drug-food; (iii). Drug-disease; and (iv). Adverse drug reactions; and (D). Evaluation of any prescription drug order and patient record for proper utilization, including over-utilization or under-utilization, and optimum therapeutic outcomes.

Prescription drug orders transmitted by facsimile or computer shall include: I. The name and address of the patient. II. The time and date of the transmission. III. The full name of the person transmitting the order. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-80(c)]. Electronically transmitted prescription drug orders shall be transmitted by the practitioner or, in the case of a prescription drug order to be transmitted via facsimile, by the practitioner or the practitioner's agent under supervision of the practitioner, to the pharmacy of the patient's choice with no intervening person or intermediary having access to the prescription drug order. For purposes of this paragraph, "intervening person or intermediary" shall not include a person who electronically formats or reconfigures data or information for purposes of integrating into and between computer or facsimile systems of practitioners and pharmacists; (2). Prescription drug orders transmitted by facsimile or computer shall include: (A). In the case of a prescription drug order for a dangerous drug, the complete name and address of the practitioner; (B). In the case of a prescription drug order for a controlled substance, the complete name, address, and DEA registration number of the practitioner; (C). The telephone number of the practitioner for verbal confirmation; (D). The name and address of the patient; (E). The time and date of the transmission; (F). The full name of the person transmitting the order; and (G). The signature of the practitioner in a manner as defined in regulations promulgated by the board or, in the case of a controlled substances prescription, in accordance with 21 C.F.R. 1301.22; (3). An electronically transmitted, issued, or produced prescription drug order which meets the requirements of this Code section shall be deemed the original order; (4). The pharmacist shall exercise professional judgment regarding the accuracy and authenticity of any electronically transmitted, issued, or produced prescription drug order consistent with federal and state laws and rules and regulations adopted pursuant to the same; (5). An electronically encrypted, issued, or produced prescription drug order transmitted from a practitioner to a pharmacist shall be considered a highly confidential transaction and the said transmission, issuance, or production shall not be compromised by unauthorized interventions, control, change, altering, manipulation, or accessing patient record information by any other person or party in any manner whatsoever between the time after the practitioner has electronically transmitted, issued, or produced a prescription drug order and such order has been received by the pharmacy of the patient's choice. For purposes of this paragraph, "unauthorized interventions, control, change, altering, manipulation, or accessing patient record information" shall not include electronic formatting or reconfiguring of data or information for purposes of integrating into and between computer or facsimile systems of practitioners and pharmacists.

Which of the following is/are TRUE about security paper for hard copy controlled substance prescription drug orders? I. Every hard copy prescription drug order for any Schedule II controlled substance written in this state by a practitioner shall be written on security paper. II. Practitioners shall employ reasonable safeguards to assure against theft or unauthorized use of security paper. III. Pharmacist may provide emergency supplies for any Schedule II controlled substance without being written on security paper. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-80.1(a)-to-(d)]. (a). Effective October 1, 2011, every hard copy prescription drug order for any Schedule II controlled substance written in this state by a practitioner shall be written on security paper. (b). A pharmacist shall not fill a hard copy prescription drug order for any Schedule II controlled substance from a practitioner unless it is written on security paper, except that a pharmacist may provide emergency supplies in accordance with the board and other insurance contract requirements. (c). If a hard copy of an electronic data prescription drug order for any Schedule II controlled substance is given directly to the patient, the manually signed hard copy prescription drug order must be on security paper approved by the board. (d). Practitioners shall employ reasonable safeguards to assure against theft or unauthorized use of security paper and shall promptly report to appropriate authorities any theft or unauthorized use.

The security paper requirements for controlled substances prescription orders shall not apply to: I. Prescriptions that are transmitted to the pharmacy by telephone. II. Prescriptions that are transmitted to the pharmacy by facsimile. III. Prescriptions that are written for outpatients of hospital and where the prescription order is given directly to the pharmacy, and the patient never has the opportunity to handle the written order. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-80.1(g)]. (g). The security paper requirements for controlled substances prescription orders shall not apply to: (1). Prescriptions that are transmitted to the pharmacy by telephone, facsimile, or electronic means; OR (2). Prescriptions written for inpatients of a hospital, outpatients of a hospital, residents of a nursing home, inpatients or residents of a mental health facility, or individuals incarcerated in a local, state, or federal correctional facility when the health care practitioner authorized to write prescriptions writes the order into the patient's medical or clinical record, the order is given directly to the pharmacy, and the patient never has the opportunity to handle the written order.

Which of the following statements are TRUE regarding a pharmacist substituting drugs? I. A pharmacist may substitute a drug with the same generic name in the same strength, quantity, dose, and dosage form as the prescribed brand name drug product, which is in the pharmacist's reasonable professional opinion. II. Whenever a substitution is made, the pharmacist shall record on the original prescription the fact that there has been a substitution and the identity of the dispensed drug product and its manufacturer. III. A patient for whom a prescription drug order is intended may instruct a pharmacist not to substitute a generic name drug in lieu of a brand name drug. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-81(a)-to-(h)]. A pharmacist may substitute a drug with the same generic name in the same strength, quantity, dose, and dosage form as the prescribed brand name drug product, which is in the pharmacist's reasonable professional opinion or a biological product with an interchangeable biological product. If a practitioner of the healing arts prescribes a drug by its generic name, the pharmacist shall dispense the lowest retail priced drug product or an interchangeable biological product which is in stock and which is, in the pharmacist's reasonable professional opinion, pharmaceutically equivalent. Whenever a substitution is made, the pharmacist shall record on the original prescription the fact that there has been a substitution and the identity of the dispensed drug product or interchangeable biological product and its manufacturer. A patient for whom a prescription drug or biological product order is intended may instruct a pharmacist not to substitute a generic name drug in lieu of a brand name drug or an interchangeable biological product in lieu of a prescribed biological product. A practitioner of the healing arts may instruct the pharmacist not to substitute a generic name drug in lieu of a brand name drug or an interchangeable biological product in lieu of a prescribed biological product by including the words "brand necessary" in the body of the prescription.

Which of the following duties shall NOT be performed by a pharmacy technician? I. Certification of a filled or finished prescription or prescription drug order. II. Weighing or measuring active ingredients without a mechanism of verification. III. Acceptance of initial oral prescriptions. A. I only B. II and III only C. III only D. All

Answer: (d) All, [Pharmacy Practice Act of Georgia 26-4-88(d) And Rules of Georgia State Board of Pharmacy 480-15-.05]. With respect to pharmacy technicians, the following functions require the professional judgment of a pharmacist, or pharmacy intern under the supervision of a pharmacist, and may not be performed by a pharmacy technician: (1). Acceptance of telephoned or other oral prescriptions; (2). Transfers of prescription drug orders from another pharmacy or transfers of a prescription drug order to another pharmacy; (3). Patient counseling; (4). Receiving information or providing information about a prescription drug order; (5). Making the determination as to whether to refill the prescription drug order; (6). Certification of a filled and finished prescription drug order; (7). Weighing or measuring active ingredients without a mechanism of verification; (8). Compounding of medication without a mechanism of verification; (9). Giving a completed prescription to the patient requesting same without the label and contents and the label being verified by a pharmacist. (10) .Reconstitution of prefabricated medication without a mechanism of verification; (11) .Verification of the constituents of final IV admixtures for accuracy, efficacy, and patient utilization; (12) .Enter of order on patient medication profiles without verification by a pharmacist; (13) .Provision of drug information that has not been prepared or approved by the pharmacist; (14). Review of the patient record for therapeutic appropriateness; and (15) .Any other act prohibited by Board rule, or law.

All controlled substances that are outdated or expired must be disposed of by which of the following means? I. By representatives of the Georgia Drugs and Narcotics Agency (GDNA). II. By agents of the U.S. Drug Enforcement Administration (DEA). III. By a reverse distributor holding a current permit issued by the Georgia State Board of Pharmacy. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-10-.14(1),(2)]. All controlled substances that are outdated or expired must be disposed of in a manner that generates a DEA Form 41 (Drug Destruction Form), a copy of which must be retained by the pharmacy. Such controlled substances can be disposed of by one of the following: (a). Representatives of the Georgia Drugs and Narcotics Agency (GDNA); (b). Agents of the U.S. Drug Enforcement Administration (DEA); or (c). A reverse distributor holding a current permit issued by the Georgia State Board of Pharmacy. (2). Dangerous drugs that are outdated or expired must be disposed of by a reverse distributor holding a current permit issued by the Georgia State Board of Pharmacy.

A pharmacist or pharmacy may receive eligible drugs for credit or reuse from long term care facilities provided that: I. The drugs were originally dispensed by that pharmacist or pharmacy to the facility. II. The pharmacist has assurance from a person in responsible charge of the drugs at the facility that the drugs have been stored in accordance with the manufacturer’s recommendations and USP standards. III. The drugs are still in the manufacturer’s packaging with the expiration date and lot number and the integrity of the product and package have been maintained. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-10-.17(4)(a)-to-(e),(6)]. A pharmacist or pharmacy may receive eligible drugs for credit or reuse from long term care facilities provided that: (a). The drugs were originally dispensed by that pharmacist or pharmacy to the facility; (b). The pharmacist has assurance from a person in responsible charge of the drugs at the facility that the drugs have been stored in accordance with the manufacturer’s recommendations and USP standards; (c). The drugs are still in the manufacturer’s packaging with the expiration date and lot number and the integrity of the product and package have been maintained; (d). The drugs are not expired and have a minimum of six (6) months remaining on the expiration date; (e). Under the pharmacist’s professional judgment the drugs are appropriate for return and reuse; and (6). A pharmacist or pharmacy which has accepted drugs for return in accordance with Section (4) of this Rule, may only re-dispense said drugs for reuse to a resident of a long-term care facility whose drugs are eligible for payment or reimbursement by the Department of Medical Assistance according to O.C.G.A.

A Georgia licensed retail pharmacy may use automated pharmacy systems or robotic pharmacy systems in the preparation of medication for dispensing provided such systems meet the which of following requirements? I. The system should be located within the licensed pharmacy. II. Medication loaded into the system can be visually identified as well as identified by bar code. III. The system provides a visual image or a description of the medication at final verification. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-10-.19(a),(b)]. Automated pharmacy systems (APS) means a mechanical system that perform operations or activities, other than compounding or administration, relative to storage, packaging, and labeling of medication for the purpose of dispensing of medication to a patient or patient’s agent. Robotic pharmacy systems (RPS) means a mechanical system controlled by a computer that performs operations or activities relative to the storage, packaging, and labeling of medication for the purpose of distribution (dispensing) of medication to a patient or a patient’s agent. A Georgia licensed retail pharmacy may use automated pharmacy systems or robotic pharmacy systems in the preparation of medication for dispensing provided such systems meet the following requirements: (1). The system collects, controls, and maintains all transaction information; (2). The system is located within the licensed pharmacy, or if in a general merchandising store, within the pharmacy department; (3). Medication loaded into the system can be visually identified as well as identified by bar code or other such secondary identification system to ensure the proper medication is being placed into and recognized as the correct medication by the system; (4). The system has adequate security systems and procedures to prevent unauthorized access to the system; (5). The system complies with federal laws and state regulations; (6). The system maintains patient confidentiality; (7). The system provides a visual image or a description of the medication at final verification. (8). The system can only be accessed by personal code.

Which of the following statements are TRUE regarding the preparation of cytotoxic substances by pharmacies? I. All cytotoxic drugs should be compounded in a vertical flow, Class II, biological safety cabinet. II. Personnel compounding cytotoxic drugs shall wear disposable masks, gloves, and gowns with tight cuffs. III. Prepared doses of cytotoxic drugs must be dispensed, labeled with proper precautions inside and outside, and delivered in a manner to minimize the risk of accidental rupture of the primary container. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-11-.02(11)(a)-to-(g)]. In addition to the minimum requirements for a pharmacy established by rules of the Board, the following requirements are necessary for those pharmacies that prepare cytotoxic drugs to insure the protection of the personnel involved. (a). All cytotoxic drugs should be compounded in a vertical flow, Class II, biological safety cabinet. Other products should not be compounded in this cabinet. (b). Personnel compounding cytotoxic drugs shall wear protective apparel. This shall include disposable masks, gloves, and gowns with tight cuffs. (c). Appropriate safety and containment techniques for compounding cytotoxic drugs shall be used in conjunction with the aseptic techniques required for preparing sterile products. (d). Disposal of cytotoxic waste shall comply with all applicable local, state, and federal requirements. (e). Written procedures for handling both major and minor spills of cytotoxic agents must be developed and must be included in the policy and procedure manual. (f). Prepared doses of cytotoxic drugs must be dispensed, labeled with proper precautions inside and outside, and delivered in a manner to minimize the risk of accidental rupture of the primary container. (g). Disposal of cytotoxic and/or hazardous wastes. The pharmacist-in-charge is responsible for assuring that there is a system for the disposal of cytotoxic and/or infectious waste in a manner so as not to endanger the public health.

Which of the following statements are TRUE regarding accessing night cabinets in the absence of a registered pharmacist in a hospital? I. Such night cabinets can only be accessed by specifically authorized personnel. II. Pre-packaged drugs available in night cabinets shall be in amounts sufficient for immediate therapeutic requirements. III. Whenever access to such cabinet(s) has been gained, written practitioner’s orders and proof of use for controlled substances must be provided. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-13-.04(7)]. When a licensed pharmacist is not physically present in the hospital, written policies and procedures shall be prepared in advance by the Director of Pharmacy for the provision of drugs to the medical staff and other authorized personnel of the hospital by use of night cabinets and/or by access to the pharmacy. Access to drugs, in the absence of a licensed pharmacist, shall be by locked cabinets or night cabinets constructed and located outside of the pharmacy area, to which only specifically authorized personnel as indicated by written policies and procedures may obtain access by key or combination, and which is sufficiently secure to deny access to unauthorized persons. The Director of Pharmacy shall, in conjunction with the appropriate committee of the hospital, develop inventory listings of those drugs to be included in such cabinet(s) and shall insure that: (a). Such drugs are available therein, properly labeled, with drug name, strength, lot number and expiration date; (b). Only pre-packaged drugs are available therein, in amounts sufficient for immediate therapeutic requirements; (c). Whenever access to such cabinet(s) has been gained, written practitioner’s orders and proof of use for controlled substances must be provided; (d). All drugs therein are inventoried no less than once per week. A system of accountability must exist for all drugs contained therein; and (e). Written policies and procedures are established to implement the requirements of this subsection.

Which of the following statements are TRUE regarding when a drug is not available from floor supplies or night cabinets during a pharmacy’s after hours? I. A drug that is required to treat the immediate needs of a patient whose health would otherwise be jeopardized may be obtained from the pharmacy pursuant to the physician’s order. II. One registered professional nurse or licensed practical nurse in any given shift may have access to the pharmacy and may remove drugs therefrom. III. The container from which the drug is removed shall be placed conspicuously to be promptly reviewed and inspected by the next pharmacist coming on duty. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-13-.04(8)]. Whenever a drug is not available from floor supplies or night cabinets, and such drug is required to treat the immediate needs of a patient whose health would otherwise be jeopardized, such drug may be obtained from the pharmacy pursuant to the practitioner’s order and the requirements of this subsection. One nursing supervisor (registered professional nurse or licensed practical nurse) in any given shift may have access to the pharmacy and may remove drugs there from. At any time that a nurse is accessing a closed pharmacy, the Director of Pharmacy must designate a licensed pharmacist, not a remote order entry pharmacist, who is available to the nurse by telephone, and who, in the event of an emergency, is available to come to the hospital. When a nurse accesses drugs directly from the closed pharmacy, the nurse must: (a). provide a copy of the order, (b). document on a suitable form the name of the drug, the strength and amount of the drug removed, the date and time it was removed, and sign the form. (c). The container from which the drug is removed shall then be placed conspicuously to be promptly reviewed and inspected by the next pharmacist coming on duty.

Which of the following may be TRUE about destroying a leftover morphine sulfate solution in an infusion bag? I. The solution must be destroyed by a licensed pharmacist or a licensed nurse and one witness. II. The two persons witnessing the destruction must sign the destruction record at the time of destruction. III. The destruction record shall be returned to the pharmacy and must be signed by the pharmacist who is ultimately responsible for the accuracy of the information contained therein. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-13-.06(4)(a)]. Full doses of controlled substances prepared for administration and not given must be destroyed by a licensed pharmacist or a licensed nurse and one witness. Any portions of controlled substances discontinued and taken from a medication delivery device shall be destroyed by a licensed pharmacist or a licensed nurse and one witness. The two persons witnessing the destruction must sign the destruction record at the time of destruction. The destruction record shall be returned to the pharmacy and must be signed by the pharmacist who is ultimately responsible for the accuracy of the information contained therein. The pharmacy must maintain a written record of the destruction and the inventory for a two-year period.

Which of the following is/are TRUE ABOUT destruction of controlled substances in Hospital Pharmacy setting? I. A securely attached wooden or metal cabinet within a locked limited-access area shall be used to store the drugs until the drugs are destroyed. II. When controlled drugs are discontinued or the patient expires, the medication shall be pulled from the active stock immediately and inventoried and verified by a pharmacist along with another licensed healthcare professional. III. A licensed pharmacist or licensed nurse and one witness must destroy the drugs. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-13-.06(4)(c)]. (c). The following methods of destruction of controlled substances are approved by the Board of Pharmacy: 1. A securely attached wooden or metal cabinet within a locked limited-access area shall be used to store the drugs until the drugs are destroyed. When controlled drugs are discontinued or the patient expires, the medication shall be pulled from the active stock immediately and inventoried and verified by a pharmacist along with another licensed healthcare professional. The inventory must be recorded into a permanent record and the drugs shall then be placed in the aforementioned cabinet. This medication shall remain within the locked cabinet until such time as it is removed for destruction. 2. The pharmacist shall establish a form, which shall include the following data: (i). Date of discontinuance or inventory date; (ii). Name of patient; (iii). Name of pharmacy; (iv). Identifying serial numbers; (v). Name and strength of the drug; and (vi). Quantity of the drugs in container(s) at the time of inventory. 3. A licensed pharmacist or licensed nurse and one witness must destroy the drugs. 4. Inventory of the drugs included in the final destruction must be taken with one copy retained by the facility. The inventory shall be certified by the two witnesses present at the destruction in the following format: "We, whose signatures appear below, certify that these controlled substances have been reconciled, accounted for, and destroyed at ___________________ (location) on _________ (date) at __________ o'clock. " Name of drug Strength of drug Dosage form Quantity of drug __________________________ (Signature and Title) __________________________ (Signature and Title) __________________________ (Signature and Title) 5. The Board and/or the GDNA may prohibit any pharmacist or hospital pharmacy from utilizing this method.

Which of the following is/are requirements to be a GDNA special agent? I. A GDNA Special Agent shall be a graduate of a recognized school or college of pharmacy and hold a current pharmacist license issued by the Georgia State Board of Pharmacy (Board). II. A GDNA Special Agent must have actively practiced pharmacy for at least two (2) years. III. A GDNA Special Agent must have completed and passed the Georgia Peace Officers Standards and Training (P.O.S.T.). A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-14-.01(1)]. A GDNA Special Agent shall be a graduate of a recognized school or college of pharmacy and hold a current pharmacist license issued by the Georgia State Board of Pharmacy (Board). Additionally, to qualify as a GDNA Special Agent, the applicant shall have: (a). Actively practiced pharmacy for at least two (2) years; (b). No private or public sanctions on his or her pharmacist license or similar licenses issued by the Board, or any other Board of Pharmacy or their equivalent; 1. No prior convictions for any crime other than minor traffic offenses; 2. Successfully passed a personal background investigation; 3. Completed and passed the Georgia Peace Officers Standards and Training (P.O.S.T.) Basic Mandate Training Course to become a Georgia P.O.S.T. Certified Peace Officer within one (1) year of being hired. GDNA Deputy Director. A GDNA Deputy Director shall be a graduate of a recognized school or college of pharmacy and hold a current pharmacist license issued by the Board. Additionally, a GDNA Deputy Director shall have at least five (5) years of full-time paid employment as a GDNA Special Agent; or as approved by the Board. A person who has been ten (10) years of full-time, paid employment in an agency similar to the GDNA as long as he or she meets the requirements for a GDNA Special Agent.

Which of the following information is/are TRUE ABOUT opioid treatment program (OTP)? I. All opioid treatment program (OTP) clinics must have an on-site pharmacy. II. An opioid treatment program (OTP) operates as a narcotic substance treatment program using narcotic replacement procedures for individuals dependant on opium, morphine, heroin or any derivative or synthetic drug in that group. III. Opioid treatment program (OTP) is authorized by the State of Georgia Department of Human Resources, the Substance Abuse and Mental Health Services Administration, and the U.S. Drug Enforcement Administration. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-18-.01 and 480-18-.02]. Opioid treatment program (OTP), is an opioid replacement program or a narcotic treatment program licensed, or otherwise authorized by the State of Georgia Department of Human Resources, the Substance Abuse and Mental Health Services Administration, and the U.S. Drug Enforcement Administration. This program operates as a narcotic substance abuse program using narcotic replacement procedures for individuals dependant on opium, morphine, heroin or any derivative or synthetic drug in that group. All opioid treatment program (OTP) clinics must have an on-site pharmacy. Opioid treatment program clinic pharmacy is a licensed pharmacy which is designated as an on-site pharmacy department located in and operated by any opioid treatment program or opiate replacement treatment program. All such pharmacies shall obtain a license by registering with the Georgia State Board of Pharmacy (Board). Such license shall be renewed biennially with the Board. Before a Board license can be issued, an opioid treatment program clinic must meet all the requirements for licensure and registration as provided by both state and federal law and all Board rules.

Faxing a prescription for Schedule II controlled drugs may serve as the original prescription only if: I. A licensed practitioner prescribes the Schedule II controlled substances for a terminally ill patient. II. A licensed practitioner prescribes the Schedule II controlled substances for a patient living in an LTCF. III. A licensed practitioner prescribes the Schedule II controlled substances for a patient living in a hospice care as certified by the Medicare. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-22-.04(1)(a), (4),(5),(6)]. Normally, a C-II prescription drug order may be transmitted by the practitioner or the practitioner’s agent, but not the patient or patient’s agent, to a pharmacy via facsimile machine or equipment. The original written, signed prescription drug order must be presented by the patient to the pharmacist prior to the actual dispensing of the schedule II (C-II) drug. Faxing a prescription for Schedule II controlled drugs may serve as the original prescription only if, I. A prescription drug order for a terminally ill patient may be transmitted directly by the practitioner or the practitioner’s agent to the dispensing pharmacy by facsimile machine. II. A prescription drug order written for any C-II substance for a resident of Long Term Care Facility (LTCF) may be transmitted directly by the prescribing practitioner or the practitioner’s agent to the dispensing pharmacy by facsimile machine or equipment. III. A prescription drug order written for any Schedule II Controlled Substance for a patient of a hospice program licensed by the State of Georgia Department of Human Resources or certified by Medicare may be directly transmitted by the practitioner or the practitioner’s agent to the dispensing pharmacy by facsimile machine or equipment.

Who may dispense a schedule II controlled drug under a Georgia State Pharmacy Law? I. a licensed pharmacist II. a licensed pharmacy intern III. a licensed pharmacy extern A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-22-.04(1)]. A pharmacist or pharmacy intern/extern shall dispense a schedule II Controlled Substance (C-II) only pursuant to a written prescription drug order. A C-II prescription drug order may be transmitted by the practitioner or the practitioner’s agent, to a pharmacy via facsimile machine or equipment. Prior to the practitioner’s agent transmitting such schedule II (C-II) prescription via facsimile machine, the C-II prescription drug order, may be transmitted by the practitioner or the practitioner’s agent, but not the patient or patient’s agent, to a pharmacy via facsimile machine or equipment. The original written, signed prescription drug order must be presented to the pharmacist prior to the actual dispensing of the schedule II (C-II) drug.

An applicant for a license as a nuclear pharmacist shall: I. Be a currently licensed pharmacist in the State of Georgia. II. Has completed a minimum of 200 contact hours of didactic instruction in nuclear pharmacy from an accredited college of pharmacy. III. Has completed a minimum of 500 hours of clinical nuclear pharmacy training. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-25-.03(2) AND Pharmacy Practice Act of Georgia 26-4-173(a),(b) ]. An applicant for a license as a nuclear pharmacist shall: (a). Be a currently licensed pharmacist in the State of Georgia, and (b). Submit to the Board a completed application and the appropriate fee, on forms to be provided by the Board, and an affidavit of training and experience which indicates that the applicant: 1. Meets the minimum requirements to use radioactive materials as required by the Department's Rules and Regulations for Radioactive Materials, and either (i). Is certified as a nuclear pharmacist by the Board of Pharmaceutical Specialties of the American Pharmaceutical Association; or (ii). Has completed a minimum of 200 contact hours of didactic instruction in nuclear pharmacy from an accredited college of pharmacy, and completed a minimum of 500 hours of clinical nuclear pharmacy training: (I). Under the direct supervision of a licensed nuclear pharmacist in a licensed nuclear pharmacy providing nuclear pharmacy service; or (II). In a certified nuclear pharmacy residency program approved by the American Society of Hospital Pharmacists or the Board; or (III). In a structured nuclear pharmacy training program of an accredited college of pharmacy.

A pharmacist shall review the patient record and each prescription drug order presented for dispensing for the purposes of promoting therapeutic appropriateness by identifying: I. Over-utilization or under-utilization. II. Therapeutic duplication. III. Clinical abuse or misuse. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-31-.01(b) and Pharmacy Practice Act of Georgia 26-4-84]. A pharmacist shall review the patient record and each prescription drug order presented for dispensing for the purposes of promoting therapeutic appropriateness by identifying: (1). Over-utilization or under-utilization; (2). Therapeutic duplications; (3). Drug-disease contraindications; (4). Drug-drug interactions; (5). Incorrect drug dosage, dosage form, or duration of drug therapy; (6). Drug-allergy interactions; and (7). Clinical abuse or misuse.

A multi-drug single-dosing container shall bear a label, which at a minimum contains: I. The name of the prescribing practitioner of each drug. II. The identifying serial number assigned to the prescription drug order for each drug contained therein. III. The directions for use, and/or time of administration or time to be taken, for each individual multi-drug single-dosing container. A. I only B. III only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy 480-9-.02(a)-to-(g)]. Each individual, customized, multi-drug single-dosing container shall bear a label, which at a minimum, contains the following: (a). The name of the patient; (b). The name of the prescribing practitioner of each drug; (c). The name, address, and telephone number of the pharmacy issuing the multi-drug single dosing container; (d). The identifying serial number assigned to the prescription drug order for each drug contained therein; (e). The name, strength, physical description, and total quantity of each drug contained therein; (f). The directions for use, and/or time of administration or time to be taken for each individual multi-drug single-dosing container; and (g). Either the dispensing or preparation date, as well as a beyond use (expiration) date for each drug contained in the multi-drug single-dosing container; the expiration date of each drug included therein shall not be longer than one (1) year from the date of preparation of the multi-drug single-dosing container.

Which of the following information related to controlled substances shall be submitted to Georgia prescription drug monitoring program (PDMP)? I. The NDC number of the monitored prescription drug. II. The number of days supply of the drug. III. Method of payment. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy Title 16, 16-13-59(a)]. For purposes of the PDMP, each dispenser shall submit to the department by electronic means information regarding each prescription dispensed for a Schedule II, III, IV, or V controlled substance.  The information submitted for each prescription shall include at a minimum, but shall not be limited to: (1) DEA permit number or approved dispenser facility controlled substance identification number; (2) Date the prescription was dispensed; (3) Prescription serial number; (4) If the prescription is new or a refill; (5) National Drug Code (NDC) for drug dispensed; (6) Quantity and strength dispensed; (7) Number of days supply of the drug; (8) Patient's name; (9) Patient's address; (10) Patient's date of birth; (11) Patient gender; (12) Method of payment; (13) Approved prescriber identification number or prescriber's DEA permit number; (14) Date the prescription was issued by the prescriber;  and (15) Other data elements consistent with standards established by the American Society for Automation in Pharmacy, if designated by regulations of the department.

Which of the following is/are TRUE about Georgia Drugs and Narcotics Agency? I. The Georgia Pharmacy Board shall appoint a director who shall be charged with supervision and control of Georgia Drugs and Narcotics Agency. II. The director, deputy director, and special agents of the Georgia Drugs and Narcotics Agency shall have the authority and power that sheriffs possess to make arrests of any persons violating or charged with violating any regulation under Georgia Pharmacy Act. III. The director, deputy director, and special agents of the Georgia Drugs and Narcotics Agency must be registered pharmacists in Georgia. A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, 26-4-29 (a),(b) and (c)]. The agency created in 1908 as the Office of the Chief Drug Inspector and known as the Georgia Drugs and Narcotics Agency since 1976 is continued in existence as the Georgia Drugs and Narcotics Agency. The board shall appoint a director who shall be charged with supervision and control of such agency. The director shall be a pharmacist registered in this state. The agency shall employ the number of personnel deemed necessary to properly protect the health, safety, and welfare of the citizens of this state. Such personnel shall be pharmacists registered in this state when employed as either special agents or the deputy director. The director, or agency personnel acting on behalf of the director, shall have the duty and the power to: (1). Visit and inspect factories, warehouses, wholesaling establishments, retailing establishments, chemical laboratories, and such other establishments in which any drugs, devices, cosmetics, and such articles known as family remedies, grocer's drugs, and toilet articles are manufactured, processed, packaged, sold at wholesale, sold at retail, or otherwise held for introduction into commerce; (2). Enter and inspect any vehicle used to transport or hold any drugs, devices, cosmetics, or any of the articles listed in paragraph (1) of this subsection; (3). Investigate alleged violations of laws and regulations regarding drugs, devices, cosmetics, or any of the articles listed in paragraph (1) of this subsection; (4). Take up samples of the articles listed in paragraph (1) of this subsection from any of the said establishments for examination and analysis by the state chemist, or under such person's direction and supervision; (5). Seize and take possession of all articles which are declared to be contraband; (6). Perform such other duties as may be directed by the board. (7). The director, deputy director, and special agents of the Georgia Drugs and Narcotics Agency shall have the authority and power that sheriffs possess to make arrests of any persons violating or charged with violating Chapter 13 of Title 16 and Chapter 3 of this title and this chapter. The deputy director and special agents shall be required to be P.O.S.T. certified peace officers under Chapter 8 of Title 35, the "Georgia Peace Officer Standards and Training Act." (8). In case of such arrest, the director, deputy director, or any of the special agents shall immediately deliver the person so arrested to the custody of the sheriff of the county wherein the offense is alleged to have been committed. The duty of the sheriff in regard to the person delivered to the sheriff by any such person arrested under power of this Code section shall be the same as if the sheriff had made the original arrest.

Information contained in the patient medication record or profile shall be considered confidential. Such information may be released to: I. the patient or the patient's authorized representative II. the prescriber or other licensed health care practitioners currently caring for the patient III. the board or its representative A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 5, 26-4-80 (d) And Rules of Georgia State Board of Pharmacy 480-16-.07(d)]. Information contained in the patient medication record or profile shall be considered confidential information. Confidential information may be released to the following: 1. The patient; 2. The patient's authorized representative; 3. The prescriber, or other licensed health care practitioners then caring for the patient; 4. Another licensed pharmacist for purposes of transferring a prescription or as a part of a patient's drug utilization review, or other patient counseling requirements; 5. The Board, or its representative; or 6. Any law enforcement personnel duly authorized to receive such information such as a GDNA agent, DEA Agent, or Georgia Medicaid Agent. In accordance with O.C.G.A. 24-9-40(b), 26-4-80 and these rules, a pharmacist may release confidential information to such persons not mentioned in 480-16-. 08(d) only upon the receipt of the following: 1. A written authorization for release signed by the patient, or his or her parents or duly appointed guardian, such as in the case of a minor; 2. An subpoena issued and signed by an authorized government official; or 3. A court order issued and signed by a judge of an appropriate court.

Who may prescribe auto-injectable epinephrine in the name of a public or private school? I. a licensed physician II. an advanced practice registered nurse III. a licensed physician assistant A. I only B. I and II only C. II and III only D. All

Answer: (d) All, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 9, 26-4-116.1]. (a). A physician licensed to practice medicine in this state, an advanced practice registered nurse and a physician assistant may prescribe auto-injectable epinephrine in the name of a public or private school for use in accordance with protocol specified by such physician, advanced practice registered nurse, or physician assistant. (b). A pharmacist may dispense auto-injectable epinephrine pursuant to a prescription issued in accordance with subsection (a) of this Code section.

All drugs dispensed by a hospital pharmacy to be used inside the hospital shall be labeled so as to identify all of the following EXCEPT: A. Brand or generic name B. Lot number C. Expiration date D. Directions for use by a patient

Answer: (d) Directions for use by a patient, [Rules of Georgia State Board of Pharmacy 480-13-.06(3)(a),(b)]. All drugs dispensed by a hospital pharmacy to be used inside the hospital shall be labeled so as to identify at a minimum, brand name or generic name, strength, lot number, and expiration date. For use outside the hospital, all drugs dispensed by a hospital pharmacy to patients about to be discharged or on leave of absence shall be labeled with the following information: 1. Name, address, and telephone number of the hospital pharmacy; 2. Date and identifying serial number; 3. Patient’s given and last name; 4. Name of drug (brand or generic) and strength; 5. Directions for use by patient; 6. Name of prescribing practitioner; 7. Required precautionary information regarding controlled substances.

Which of the following is classified as a Schedule A Poison? A. Colchicum B. Belladonna C. Nux vomica D. Essential oil of bitter almonds

Answer: (d) Essential oil of bitter almonds, [Rules of Georgia State Board of Pharmacy Title 26, Chapter 4, Article 9, 26-4-160]. No person shall furnish by retail sale any poison enumerated in this Code section without distinctly labeling the bottle, box, vessel, or paper in which the poison is contained, and also the outside wrapper or cover thereof, with the name of the article, the word "Poison," and the name and place of business of the person who furnishes the same. (1). Schedule "A." Arsenic and its preparations, corrosive sublimate, white precipitate, red precipitate, biniodide of mercury, cyanide of potassium, hydrocyanic acid, strychnia, and all other poisonous vegetable alkaloids and their salts; essential oil of bitter almonds, opium and its preparations, except paregoric and other preparations of opium containing less than two grains to the ounce; and (2). Schedule "B." Aconite, belladonna, colchicum, conium, nux vomica, henbane, creosote, digitalis, and their pharmaceutical preparations; croton oil, chloroform, chloral hydrate, sulfate of zinc, mineral acids, carbolic acid, and oxalic acid.

The book that contains all the transactions pertaining to sales or delivery of poisonous drugs shall be preserved for at least: A. one year from the date of last transaction. B. three years from the date of last transaction. C. four years from the date of last transaction. D. five years from the date of last transaction.

Answer: (d) Five years from the date of last transaction, [Pharmacy Practice Act of Georgia 26-4-161]. No licensed pharmacist shall sell or deliver any of the poisons without first making an entry in a book for that purpose, stating the date of the delivery, the name and address of the person receiving the poison, the name and quantity of the poison, the purpose for which it is represented by such person to be required, and the name of the dispenser. Such book shall always be open for inspection by the proper authorities and shall be preserved for reference for at least FIVE years from the date of last transaction.

Phenergan with Codeine syrup is classified as: A. Schedule II B. Schedule III C. Schedule IV D. Schedule V

Answer: (d) Phenergan with Codeine syrup is classified as a Schedule V controlled drug, [Controlled Substance Act of Georgia 16-13-29]. List of Schedule V controlled drugs: ______________________________ Codeine preparations - 200 mg per 100 ml or 100 gm (Robitussin AC, Phenergan with Codeine) Difenoxin preparations - 0.5 mg Difenoxin + 25mcg Atropine sulfate (Motofen) Dihydrocodeine preparations 100 mg per 100 ml or 100 gm Diphenoxylate preparations- 2.5 mg Diphenoxylate + 25mcg Atropine sulfate (Lomotil, Logen) Ethylmorphine preparations 100 mg per 100 ml or 100 gm Opium preparations - 100 mg per 100 ml or gm (Parepectolin, Kapectolin PG, Kaolin Pectin P.G.) Pseudoephedrine Lyrica - Pregabalin Vimpat - Lacosamide Potiga - Ezogabine Pyrovalerone Briviact-Brivaracetam Epidiolex-Cannabidiol

Which of the following is the TRUE meaning of an Issuing Pharmacy in reference to a Home Health Agency? a. It is a type of pharmacy that possesses the power to issue opioid-related drugs. b. It is a type of pharmacy that deals with the selling of orphan drugs. c. It is a type of pharmacy that is authorized to issue sterile drug intravenous maintenance kits for use in a home health care setting. d. It is a type of pharmacy that contracts with one or more groups of practitioners to participate in a double blind study. A. a B. b C. c D. d

Answer: c only, [Rules of Georgia State Board of Pharmacy 480-17-.02(4)]. Issuing Pharmacy means a pharmacy licensed as a retail pharmacy by the Georgia State Board of Pharmacy that is authorized to issue Sterile Drug Intravenous (IV) Maintenance Kits (SDM Kits) for use in a home health setting by registered professional nurses employed or contracted by a licensed home health agency. Sterile Drug Intravenous (IV)Maintenance Kits (SDM Kits) are sealed containers whose contents are strictly limited to the drugs sterile saline, sterile water, and diluted heparin, and which can only be distributed by an Issuing Pharmacy to professional registered nurses employed or contracted by a home health care agency.

Who may have authority to conduct inspections of any licensed retail pharmacy? I. GDNA Special Agents II. Deputy Directors of GNDA III. Agents of Georgia State Pharmacy Board A. I only B. I and II only C. II and III only D. All

I and II only, [Rules of Georgia State Board of Pharmacy 480-10-.01(3),(4)]. (1). Every retail pharmacy, possessing or having possessed any controlled substances and/or dangerous drugs, within a period of two years, and/or possessing any record related to the same, which is required to be kept by O.C.G.A. T. Ch. 16-13, shall exercise diligent care in protecting such controlled substances and/or dangerous drugs and/or records related to the same from loss or theft. (a). Every licensed retail pharmacy shall ensure that all controlled substances and/or dangerous drugs are purchased from and/or returned to firms holding a current permit issued by the Georgia State Board of Pharmacy (Board). This requirement can be met by a pharmacy maintaining a copy of such firms’ current Georgia Board permit. (2). All controlled substances and/or dangerous drugs shall be kept in a secure place accessible only to an authorized person. (3). Special Agents or Deputy Directors of the Georgia Drugs and Narcotics Agency (GDNA) shall have the authority to conduct inspections of any place or premises used by any such licensed retail pharmacy in relation to such controlled substances and/or dangerous drugs and/or any records pertaining to their acquisition, dispensing, disposal, or loss. (4). GDNA Special Agents or Deputy Directors shall have the authority to examine, copy, or remove all such records, and to examine, copy, remove, or inventory all such controlled substances and/or dangerous drugs. (a). It shall be the responsibility to such person possessing such controlled substances and/or dangerous drugs and/or records to make the same available for such inspection, copying, examination, or inventorying by said GDNA Special Agents or Deputy Directors. (b). At the conclusion of an inspection, the GDNA Special Agents or Deputy Director examining said drugs and/or records shall have the responsibility of providing to such retail pharmacy a copy of a written inspection report on which any deficiencies or violations are made along with any recommendations, if any, concerning the satisfactory storage, keeping, handling and security of controlled substances and/or dangerous drugs.

All of the following are Schedule I controlled drugs EXCEPT: A. Heroin B. LSD C. Methylphenidate D. Marijuana

List of Schedule I controlled drugs: _____________________________ Difenoxin (Lyspafen) Dihydromorphine Heroin (Diacetylmorphine, diamorphine) Lysergic acid diethylamide (LSD, lysergide) Marijuana (Cannabis, marijuana) Mescaline Peyote

A drug is found to be under-strength, although it is not used to treat a life-threatening disease. What type of recall will be required? A Class I B Class II C Class III D Class IV E No recall will be required

Question 4 Explanation: Class I recalls are for dangerous or defective products that may cause serious harm. Class II recalls are for products that may cause a temporary health problem. Class III recalls are for products that are unlikely to cause any health problems.